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 I. SUMMARY 
______________________________________________________________________________ 
Introduction: This health consultation was conducted because residents and former 
health officials of the community of New Bedford, Massachusetts, were 
concerned about possible environmental exposures from the New Bedford 
Business Park and potential health impacts (i.e., cancer) in two nearby 
neighborhoods.   
______________________________________________________________________________ 
Overview:  The MDPH has reached several important conclusions about possible 
environmental exposures from the New Bedford Business Park and cancer 
incidence in the census tracts/neighborhoods of concern.   
______________________________________________________________________________ 
Conclusion 1: The MDPH concluded that health effects in nearby residents are not 
expected to result from environmental exposures associated with impacts 
to drinking water or indoor air at the former BorgWarner, Polymerine, 
Tallyrand, and Polaroid sites in the past, present, or future.   
 
Basis for Decision: Groundwater at the former BorgWarner, Polymerine, Tallyrand and 
Polaroid sites was not used as a source of drinking water historically, nor 
is it at present.  The surrounding neighborhoods are generally served by 
the City of New Bedford Water Department.  Although private drinking 
water wells may exist on Braley Road, they are located upgradient.  
Therefore, ingestion of or dermal contact with contaminants in 
groundwater was eliminated as an exposure pathway in the past, present 
and future.  In addition, exposure of nearby residents to groundwater 
contaminants via vapor intrusion is not expected in the past, present and 
future due to the distance to the nearest residences.   
______________________________________________________________________________ 
Conclusion 2: The MDPH concluded that incidentally eating or touching soil at the 
former Polymerine or former Tallyrand sites in the past, present or future 
is not expected to result in health effects.   
 
Basis for Decision: Past activities at the former Polymerine and Tallyrand sites resulted in 
chemical contaminants in on-site soil.  While it is possible that some 
trespassers could have come into contact with chemical contaminants at 
either site, the available information does not suggest health impacts 
would be expected.  Conservative assumptions about the frequency and 
duration of potential exposures demonstrate that the levels of chemical 
contaminants that could get into an older child’s body are below levels 
that would result in adverse non-cancer or cancer health effects.   
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 Remediation at the former Polymerine and Tallyrand sites included the 
removal of contaminated soil.  Confirmatory sampling at the former 
Polymerine site indicated that concentrations of PCBs still remain in on-
site soils at levels above the applicable regulatory clean-up standards.  
 Although PCB concentrations at the former Tallyrand site are not expected 
to exceed the USEPA action level, it is possible that exceedances of 
health-based comparison values could still occur.  Using conservative 
assumptions about the frequency and duration of potential exposures, 
present and future incidental ingestion of or dermal contact with PCBs in 
soil by trespassers at either the former Polymerine or Tallyrand sites are 
not expected to result in adverse non-cancer or cancer health effects.     
______________________________________________________________________________ 
Conclusion 3: The MDPH concluded that incidentally eating or touching soil at the 
former BorgWarner or Polaroid sites in the past, present or future is not 
expected to result in health effects.   
 
Basis for Decision: Due to the depth below ground surface at which contamination was 
detected at the former BorgWarner and Polaroid sites, no exposure 
pathways were complete in the past, present or future.  In addition, 
remedial activities at both sites included the excavation and disposal of 
contaminated soil.   
______________________________________________________________________________ 
Conclusion 4: The MDPH concluded that breathing chemicals in outdoor air impacted by 
emissions from the former Polaroid facility was possible for nearby 
residents when the facility was in operation.  While acute impacts at that 
time may have been possible, there are no ambient air data available to 
evaluate whether facility emissions may have resulted in health impacts in 
the past.  Based on available hospital discharge data, the number of asthma 
hospitalizations within zip code 02745 during 2000-2003 does not appear 
to be related to the level of emissions of MEK, a respiratory irritant, from 
the former Polaroid facility.   
 
Basis for Decision: Since there are no historical ambient air monitoring data available for the 
former Polaroid facility or the surrounding neighborhoods, it is difficult to 
evaluate whether facility emissions may have resulted in chemical 
concentrations in ambient air greater than health-based comparison values.  
However, since MEK is a respiratory irritant, the MDPH examined 
hospital discharge data for asthma hospitalizations of residents of zip code 
02745 during 2000-2003.  This four-year time period reflects the most 
complete data available through 2003, after which point MEK was no 
longer emitted from the former Polaroid facility.  Overall, there does not 
appear to be a relationship between the level of emissions of MEK from 
the former Polaroid facility and the number of asthma hospitalizations 
within the zip code.  The level of emissions of MEK generally decreased 
over this time period and a corresponding decrease in the number of 
asthma hospitalizations was not observed.   
______________________________________________________________________________ 
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Conclusion 5: The MDPH concluded that the incidence of bladder and breast cancer in 
the census tract (CT) that contains the Briarwood Development was either 
less than or about as expected during 1996-2000 and 2001-2005 compared 
 to the statewide cancer experience.  Although no elevations were 
statistically significant, the incidence of kidney/renal pelvis, 
liver/intrahepatic bile duct, lung and bronchus, and prostate cancer was 
slightly elevated or elevated during one or both time periods evaluated.     
 
Basis for Decision: To determine whether the incidence of cancer in CT 6501.01 was 
elevated, the observed number of cancer diagnoses in the CT was 
compared to the number that would be expected based on the statewide 
cancer rate.  In each of the two time periods evaluated (1996-2000 and 
2001-2005), the incidence of bladder and  breast occurred either less than 
or about as expected in both genders.   
 
 The incidence of kidney/renal pelvis cancer was about as expected among 
males in both time periods.  Among females, kidney/renal pelvis cancer 
was slightly elevated during 1996-2000 (5 diagnoses observed compared 
to about 2 expected) but the difference was not statistically significant.   
 
 Among males, the incidence of liver/intrahepatic bile duct cancer was 
slightly elevated during both 1996-2000 (2 diagnoses observed compared 
to 1 expected) and 2001-2005 (3 diagnoses observed compared to about 1 
expected).  Neither difference was statistically significant.  Among 
females, the incidence of this cancer type was as expected during both 
time periods. 
 
The incidence of lung and bronchus cancer was either less than or about as 
expected among females during both time periods evaluated.  Among 
males, the incidence of lung and bronchus cancer was elevated during 
1996-2000 (19 diagnoses observed compared to about 13 expected) but 
the elevation was not statistically significant.  During 2001-2005, the 
incidence of lung and bronchus cancer among males was about as 
expected.   
 
The incidence of prostate cancer was less than expected during 1996-2000 
but greater than expected during 2001-2005 (31 diagnoses observed 
compared to about 25 expected).  This difference was not statistically 
significant.   
 
Age at diagnosis, histology (cell type), and the temporal pattern of 
diagnoses were evaluated separately for those individuals diagnosed with 
kidney/renal pelvis cancer, liver/intrahepatic bile duct, lung and bronchus 
cancer, or prostate cancer.  No unusual patterns emerged.  Although some 
diagnoses occurred among individuals whose residences at the time of 
diagnosis were in relative close proximity to one another, the geographic 
distribution generally followed the population density of the CT.   
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 Review of risk factor information suggests that tobacco use likely played 
some role in the development of kidney/renal pelvis and lung and 
bronchus cancer among some individuals.  Occupational exposures may 
have also been important in the development of these cancer types among 
some individuals.  It should also be noted that exposure to radon has been 
identified as the second leading cause of lung and bronchus cancer, and 
the leading cause among nonsmokers.  Testing of individual homes is the 
only way to find out the radon level in a home.   
______________________________________________________________________________ 
Conclusion 6: The MDPH concluded that the incidence of bladder, breast, and lung and 
bronchus cancer in the census tract (CT) that contains the Pine Hill Acres 
neighborhood occurred either less than or about as expected during 1996-
2000 and 2001-2005 compared to the statewide cancer experience.  
Although no elevations were statistically significant, the incidence of 
kidney/renal pelvis, liver/intrahepatic bile duct and prostate cancer was 
either slightly elevated or elevated during one of the two time periods 
evaluated.   
 
Basis for Decision: To determine whether the incidence of cancer in CT 6501.02 was 
elevated, the observed number of cancer diagnoses in the CT was 
compared to the number that would be expected based on the statewide 
cancer rate.  In each of the two time periods evaluated (1996-2000 and 
2001-2005), the incidence of bladder, breast, and lung and bronchus 
cancer in both genders occurred either less than or about as expected.   
 
 The incidence of kidney/renal pelvis cancer among females occurred 
either less than or about as expected during both time periods.  Among 
males, the incidence of kidney/renal pelvis cancer was slightly elevated 
during 1996-2000 (4 diagnoses observed compared to about 2 expected).  
This elevation, however, was not statistically significant.  During 2001-
2005, the incidence of kidney/renal pelvis cancer among males was about 
as expected.   
 
 In CT 6501.02, no diagnoses of liver/intrahepatic bile duct cancer were 
observed during 1996-2000.  During 2001-2005, the incidence of 
liver/intrahepatic bile duct cancer among males was about as expected (1 
observed diagnosis compared to about 1 expected) whereas that among 
females was slightly elevated (1 observed diagnosis compared to 0 
expected).  These differences were not statistically significant.   
 
 The incidence of prostate cancer was less than expected during 1996-2000 
but greater than expected during 2001-2005 (19 diagnoses observed 
compared to about 16 expected).  This slight elevation was not statistically 
significant.   
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 Age at diagnosis, histology (cell type), and the temporal pattern of 
diagnoses were evaluated separately for those individuals diagnosed with 
kidney/renal pelvis, liver/intrahepatic bile duct and prostate cancer.  No 
unusual patterns emerged for these cancer types.  Although some 
diagnoses occurred among individuals whose residences at the time of 
diagnosis were in relative close proximity to one another, the geographic 
distribution generally followed the population density of the CT.   
______________________________________________________________________________ 
Next Steps:  The MDPH recommends no further investigation of cancer incidence in 
CTs 6501.01 and 6501.02 at this time.   
 
 The MDPH recommends that all residences in Massachusetts be tested 
for radon.  The only way to determine if your home has a radon problem is 
to do a radon test.  For further questions about radon, you may contact 
MDPH/BEH’s Radiation Control Program toll free at (800) 723-6695 for 
advice on home testing.   
 
 The MDPH recommends that residents who would like more 
information about quitting smoking contact the Massachusetts Tobacco 
Cessation and Prevention Program at 1-800-Quit-Now or 1-800-784-8669 
or visit the website http://makesmokinghistory.org/.   
______________________________________________________________________________ 
For More Information: If you have questions about this report, you may call the 
MDPH/BEH at 617-624-5757. 
 II. Introduction and Statement of Issues 
At the request of community members and former New Bedford health officials, the Community 
Assessment Program (CAP) within the Massachusetts Department of Public Health’s (MDPH) 
Bureau of Environmental Health (BEH) conducted an evaluation of possible environmental 
exposures related to the New Bedford Business Park and cancer incidence for two New Bedford 
census tracts in the vicinity of the business park (see Figure 1)1.  Community members were 
concerned about cancer in two neighborhoods in northern New Bedford near the business park as 
well as possible dumping, possible groundwater and surface water contamination, and possible 
impacts of air emissions from a former Polaroid Corporation (Polaroid) manufacturing facility.   
 
The New Bedford Business Park was established in 1960 and currently consists of more than 40 
businesses, including, but not limited to, a solar energy facility, a machine shop, a steel 
fabricator, print shops, and manufacturers of thin-film photovoltaic material, golf balls, electric 
capacitors, plastics, and circuit boards (Davis 2003; Cohen 2008; Brown 2011; GNBIF 2011).  A 
number of properties within the New Bedford Business Park have had releases of oil or other 
hazardous material that have been reported to the Massachusetts Department of Environmental 
Protection (MDEP) under the statewide hazardous waste site cleanup program.  This program, 
referred to as the Massachusetts Contingency Plan (MCP), was established in 1983 under 
Chapter 21E of Massachusetts General Laws (M.G.L. c21E, 310 CRM 40.0000).  It authorizes 
the MDEP to enforce regulations governing the investigation and cleanup of oil and hazardous 
material release sites, known as “21E sites.”  Releases can vary widely with respect to the 
source, materials involved and the amount released, and the geographic extent of contamination.  
Many of the releases that occurred within the New Bedford Business Park were addressed with 
an immediate action response and, soon thereafter, were considered by the MDEP to pose no 
significant risk of harm to health, safety, public welfare and the environment.   
 
                                                 
1 This report was supported in part by funds from a cooperative agreement with the Agency for Toxic Substances 
and Disease Registry (ATSDR), U.S. Department of Health and Human Services.  This document has not been 
reviewed and cleared by ATSDR.   
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 At the time that this evaluation was initiated, three properties within the New Bedford Business 
Park had a release of oil or hazardous material that was currently being investigated under the 
MCP and cleanup activities were ongoing: the former BorgWarner TorqTransfer Systems, Inc. 
facility (BorgWarner), the former Polymerine site and the former Tallyrand site.  Furthermore, 
two releases have occurred at the former Polaroid facility (MDEP 2009).  Although they have 
been closed out under the MCP, the releases at the former Polaroid facility were included in this 
investigation since this facility was of specific interest to community members.   
 
To address community concerns about possible environmental exposures, the CAP reviewed 
available environmental data for the sites of the former BorgWarner, Polymerine, Tallyrand, and 
Polaroid facilities.  In addition, the CAP considered potential ways that people may come into 
contact with contaminants in soil, surface water, sediment, groundwater, and indoor and outdoor 
air associated with these sites.  The available environmental data were compared to health-based 
screening values to determine whether there may be potential health impacts to nearby residents.   
 
The U.S. Census Bureau subdivides the City of New Bedford into 31 smaller geographic areas 
known as census tracts (CTs).  To address community concerns about cancer incidence, the CAP 
reviewed the incidence of six cancer types (bladder, breast, kidney/renal pelvis, liver/intrahepatic 
bile duct, lung and bronchus, and prostate cancer) in the two CTs (6501.01 and 6501.02) in 
which the neighborhoods of concern are located (see Figure 2).  The six cancer types evaluated 
were chosen based on residents’ concerns over suspected elevations.  The incidence of each of 
these cancer types was compared to the incidence in the state of Massachusetts as a whole.  
Cancer incidence data for New Bedford were obtained from the Massachusetts Cancer Registry 
(MCR).  At the time of this evaluation, the most recent and complete cancer incidence data 
available from the MCR were through the year 2005.  Cancer incidence data reported for the 
years 1996 through 2005 were evaluated.  Additionally, available information about known or 
suspected risk factors for developing these cancers was evaluated.   
III. Objectives 
The specific objectives of this investigation were as follows:  
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  To evaluate the extent to which contamination and/or emissions related to the former 
BorgWarner, Polymerine, Tallyrand and Polaroid facilities at the New Bedford Business 
Park could result in exposure to people in the area and whether adverse health effects 
might be possible, if exposure occurred.   
 
 To discuss possible exposures related to contamination and/or emissions related to the 
former BorgWarner, Polymerine, Tallyrand and Polaroid facilities in the context of the 
available scientific and medical literature on cancer to determine whether further 
investigation or public health actions may be warranted.   
 
 To review the incidence of six cancer types (bladder, breast, kidney/renal pelvis, 
liver/intrahepatic bile duct, lung and bronchus, and prostate cancer) in the two CTs 
(6501.01 and 6501.02) containing the neighborhoods of concern.   
 
 To evaluate the geographic distribution of individuals diagnosed with these six cancer 
types in CTs 6501.01 and 6501.02 to see if there are any unusual spatial patterns.   
 
 To review descriptive information available from the MCR for individuals diagnosed 
with these six cancer types in CTs 6501.01 and 6501.02 to see if there are any unusual 
patterns related to known or suspected risk factors for developing these diseases.   
IV. Evaluation of Potential Community Exposure Pathways and Health 
Concerns 
This evaluation was initiated in response to community concerns about cancer in two 
neighborhoods in northern New Bedford and possible environmental exposures from the nearby 
New Bedford Business Park (see Figure 1).  In particular, community members were concerned 
about possible dumping, possible groundwater and surface water contamination, and possible 
impacts of air emissions from the Polaroid facility.   
 
In order to address concerns of possible dumping prior to the construction of the Briarwood 
Estates development, the CAP contacted the New Bedford Department of Environmental 
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 Stewardship (NBDES).  Staff in NBDES reported that no documentation could be located that 
indicated any dumping had occurred.  In addition, no record of a cease and desist order, which 
reportedly had been placed on the developer during construction, could be found (S. Alfonse, 
New Bedford Department of Environmental Stewardship, personal communication, 2008).    
 
At the initiation of this evaluation, three properties within the New Bedford Business Park had a 
reported release of oil or hazardous material that was being investigated under the MCP and 
cleanup activities were still underway: the former BorgWarner, Polymerine and Tallyrand sites.  
The former Polaroid facility has had two releases, both of which were remediated and have been 
closed out under the MCP (MDEP 2009).  These releases were included in this investigation 
because community residents were specifically concerned about the former Polaroid facility.   
 
The release at the former BorgWarner facility (Release Tracking Number 4-0389), located at 200 
Theodore Rice Boulevard, was reported to the MDEP in 1987 and involved petroleum 
contamination in groundwater and soil due to an underground storage tank (UST).  Possible 
sources of petroleum also included metal parts drainage bins and underground piping associated 
with former USTs, all of which were removed from the site.  Approximately 2,500 cubic yards 
of soils heavily impacted by petroleum were removed during remedial activities in 1987 (M&A 
1999).  A dual-phase product recovery/groundwater treatment system was installed in 2000 to 
recover subsurface light non-aqueous phase liquid (LNAPL).  In 2006, the system was shut down 
for modification and began re-operating in September 2010 as a total fluid recovery system that 
discharges treated groundwater to the New Bedford Publicly Owned Treatment Works (POTW) 
via a sewer.  In the interim, absorbent media was deployed in the recovery wells to continue 
product recovery.  It should be noted that polychlorinated biphenyls (PCBs) were detected in 
LNAPL at the site but all groundwater monitoring results for PCBs have been non-detect.  
Currently, the release is being regulated under the MCP and has a Remedy Operation Status 
(REMOPS), indicating that a remedial system is being operated for the purpose of achieving a 
permanent solution (M&A 2010; MDEP 2008, 2009).  Contamination identified at the site is 
reportedly completely below grade and limited to within the boundaries of the property.  
Therefore, residents of nearby neighborhoods or trespassers who may visit the Business Park are 
not expected to have direct contact with contaminated soil or groundwater.  In addition, the 
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 surrounding neighborhoods are generally served by the City of New Bedford Water Department, 
which obtains its drinking water from surface water bodies (M&A 1999).  While it is possible 
that private drinking water wells may exist on Braley Road, they are located upgradient of the 
former BorgWarner site.  The groundwater beneath the site flows west/southwest toward 
Duchaine Boulevard (B. Sylvia, New Bedford Department of Inspectional Services, personal 
communication, 2009; New Bedford Department of Public Infrastructure, personal 
communication, 2009; M&A 1999).  The groundwater beneath the site has also been identified 
by the MDEP as a Non-Potential Drinking Water Source area.  Due to the distance from the site 
to the nearest residences, exposure of nearby residents to contaminants via vapor intrusion (i.e., 
the volatilization of chemicals from groundwater through soil and into the indoor air of a 
building) would not have been expected in the past, nor in the present or future (M&A 1999; 
ITRC 2007; USEPA 2002).  As a result, there are no completed soil or groundwater exposure 
pathways for nearby residents and this release was not evaluated further.   
 
With respect to the former Polymerine, Tallyrand and Polaroid sites, the CAP contacted the 
MDEP to obtain available environmental information pertaining to these three sites.  Available 
environmental sampling data were reviewed, and a screening evaluation was conducted to 
identify those substances that may need to be considered for further analysis to determine 
potential health impacts to residents.  The screening analysis identified maximum concentrations 
of contaminants detected in various environmental media (i.e., soil and water) and compared 
those concentrations to health-based comparison values.  Comparison values are set well below 
levels that are known or anticipated to result in adverse health effects.  Contaminant 
concentrations that exceed comparison values will not necessarily affect one’s health.  For a 
contaminant to impact one’s health, it must not only be present in the environmental media, but 
one must also come in contact with it.  Therefore, if a concentration of a contaminant is greater 
than the appropriate comparison value, the potential for exposure to the contaminant should be 
further evaluated to determine whether exposure is occurring and whether health effects might be 
possible as a result of that exposure.  An evaluation of potential exposure pathways was 
conducted to determine whether contamination identified at the sites could impact the health of 
nearby residents of New Bedford in the past, present, or future.  
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 For each site discussed below, background information on the history of the site is provided 
followed by discussion of the status of each site within MDEP’s investigation and cleanup 
process.  An evaluation of the potential for exposure of New Bedford residents to site-related 
contamination is provided and the available environmental data are compared to health-based 
screening values to determine the potential for health impacts to residents.   
A. Former Polymerine Site 
Site Description 
The former Polymerine site is located at 241 Duchaine Boulevard within the New Bedford 
Business Park in New Bedford.  The property is currently owned by the City of New Bedford 
and was acquired through a tax taking in 2006.  The 8-acre property consists of a single-story 
manufacturing building with 33,757 square feet that was built circa 1960, an asphalt-paved 
parking area, landscaped areas, undeveloped wooded and wetland areas, and an abandoned 
railroad spur (New Bedford 2008a).  A portion of the on-site building is currently leased by New 
England Plastics Corporation (NEP) and operates as a plastics manufacturing facility.  The 
remaining portion of the building is vacant.  Until recently, it had been used as a warehouse by 
Aquapoint, Inc., a wastewater treatment system manufacturer (Roy F. Weston 1998; Tighe & 
Bond 2008).   
 
The property is bordered to the east by Duchaine Boulevard and Alberox Corporation (also 
known as Morgan Advanced Ceramics), to the south by Black Pond and the Titleist Acushnet 
Company Ball Plant III, to the west by Hobomock Swamp and Conrail Railroad tracks, and to 
the north by undeveloped woods and wetlands (Roy F. Weston 1998; Tighe & Bond 2008).  The 
nearest residence is located approximately 1,300 feet (0.25 miles) to the northeast along Braley 
Road (MassGIS 2005).  
 
Site History 
From 1960 through the late 1990s, the property was operated by Polymerine (formerly known as 
Polyply) as a manufacturing facility of composite fiberglass boards produced through a process 
that laminated sheets of fiberglass impregnated with epoxy.  Hazardous materials used or 
generated by manufacturing processes included solvents, resins, waste oil, fuel oil, and PCB-
11 
 containing heat transfer oil (Roy F. Weston 1998, 2001).  Hazardous waste generated at the 
former Polymerine site included 2-propanone and acetone, both of which are ignitable wastes.  
Two violations were cited at the facility but both were subsequently resolved (Tighe & Bond 
2008).   
 
In September 1993, the MDEP was notified of a release of oil or hazardous substances at the 
Polymerine site and assigned the Release Tracking Number (RTN) 4-0001347 (MDEP 2009).  
Based on a review of available environmental data for the former Polymerine site, assessment 
activities included the collection of groundwater, soil, sediment and interior building surface 
samples.  The maximum levels of contaminants detected at the site were compared to health-
based comparison values to determine if further evaluation was necessary.    
 
Groundwater samples contained acetone, toluene, phenanthrene, PCBs and zinc at concentrations 
below applicable MDEP Method 1 GW-1 standards (MDEP 2008,; MassGIS 2008; Tighe & 
Bond 2008, 2009).  PCBs were detected in wipe samples collected from interior building 
surfaces with concentrations exceeding the Toxic Substance Control Act (TSCA) High 
Occupancy Standard of 10 micrograms per 100 square centimeters (µg/100 cm2) (USEPA 1991; 
USEPA 2005; Roy F. Weston 1998; Tighe & Bond 2008).  Sediment samples collected from the 
abutting wetland contained concentrations of PCBs that exceeded soil comparison values 
(ATSDR 2008a; Tighe & Bond 2009).  Soil samples collected on-site contained elevated 
concentrations of PCBs and the metal copper that exceeded comparison values2 (ATSDR 2008a; 
Roy F. Weston 1998; Tighe & Bond 2008).  See Table 1 for a summary of the maximum 
concentrations of contaminants detected in on-site soil and sediment samples that exceeded 
comparison values.   
 
                                                 
2 It has been reported that an on-site soil sample collected in 1993 contained elevated concentrations of total 
petroleum hydrocarbons (TPH) that exceeded soil comparison values (24,000 ppm).  However, documentation of 
this sample with its location and depth could not be located (Tighe & Bond 2008).  In addition, data on the 
constituent composition of the TPH detected on-site were not available.  TPH is a mixture of many different 
compounds, all of which originate from crude oil, and affect the body in different ways.  Although there are no 
federal regulations or guidelines for TPH as a single entity, the government has developed regulations and 
guidelines for some of the specific TPH fractions and compounds.  Due to the lack of documentation and 
appropriate health-based comparison values, TPH was not evaluated further.   
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 In 1998, the property owner excavated approximately 220 tons of PCB-contaminated soil from 
the site in response to a Unilateral Administrative Order (UAO) from the U.S. Environmental 
Protection Agency (USEPA).  The excavated soil was stockpiled on the property until it was 
disposed of in 2000.  From 2000 through 2001, the USEPA conducted removal activities at the 
site, excavating and disposing of approximately 2,000 tons of PCB-contaminated soil off-site.  
Excavation of soil with PCB concentrations exceeding the site-specific USEPA action level of 2 
ppm was conducted and continued to depths where PCB concentrations were less than 2 ppm or 
until the water table was encountered.  The excavation was generally continued to depths 
between 12 and 30 inches below ground surface with some areas excavated to depths of between 
60 and 72 inches below ground surface.  Several areas of soil with PCB concentrations 
exceeding the USEPA action level located at or below the water table were covered with 
geotextile fabric and a layer of clean soil.  Site restoration consisted of backfilling and grading 
soil as well as planting vegetation and trees (Roy F. Weston 2001).  Post-excavation 
confirmatory soil samples were collected in 2000, 2001 and 2008.  Confirmatory soil samples 
contained concentrations of PCBs (e.g., maximum of 2,600 ppm) that still exceeded soil 
comparison values (Tighe & Bond 2009).  Since the removal actions were focused on PCB 
contamination, concentrations of copper remaining in on-site soil were not measured.  
Presumably, the concentration of copper has been reduced by the soil excavation since the 
contaminants were co-located.   
 
Site Status 
The former Polymerine site is currently classified by the MDEP as a Tier II disposal site under 
the MCP.  The City of New Bedford has assumed the role of Responsible Party (RP) and has 
agreed to initiate voluntary Comprehensive Response Actions (CRAs) as required by the MCP 
and TSCA.  To date, a Phase I Initial Site Investigation, Tier Classification Report, and a Phase 
II Comprehensive Site Assessment (CSA) have been submitted to the MDEP (Tighe & Bond 
2008, 2009).   
 
Groundwater within the western portion of the former Polymerine site is located within an area 
designated by MDEP as a potentially productive aquifer.  However, groundwater samples 
collected in this area did not contain contaminants above the applicable MDEP Method 1 GW-1 
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 standards (MDEP 2008; MassGIS 2008; Tighe & Bond 2008, 2009).  It is important to note that 
groundwater at the former Polymerine site is not used for drinking water.  The on-site building 
and the surrounding neighborhoods are served by the City of New Bedford Water Department, 
which obtains its drinking water from surface water bodies.  Testing of the drinking water is 
conducted on a regular basis, as is required of all municipal drinking water sources.  No private 
drinking water wells are located within 500 feet of the site (Tighe & Bond 2009).  As a result, 
there is no completed groundwater exposure pathway and, hence, data were not evaluated for 
possible exposures through household water use.   
 
Although the groundwater at the former Polymerine site could be a potential source of indoor air 
exposures in the on-site building (a private business) since the average depth to groundwater is 
less than 15 feet below ground surface and the release area is located within 30 feet of an 
occupied structure, vapor intrusion was eliminated as an exposure pathway for nearby residents 
in the past, present and future due to the distance to the nearest residences.  Therefore, vapor 
intrusion as a potential exposure pathway at the former Polymerine site was not evaluated further 
in this health consultation (Tighe & Bond 2009; ITRC 2007; USEPA 2002).   
 
Prior to remediation in 2001, it is possible that a trespasser, such as an older child, may have 
been exposed through incidental ingestion of or dermal contact with PCBs and copper detected 
in on-site surface soil and sediment at levels above comparison values.  However, it is important 
to consider that comparison values are based on a residential exposure scenario, and it is unlikely 
that a trespasser would have had contact with on-site surface soil and sediment for a comparable 
frequency and duration of time as a resident, i.e., daily over a lifetime.  The site is located within 
an industrial area and, hence, trespassing would occur only occasionally, if at all.     
 
Although unlikely, assuming that an older child trespassed on the site and inadvertently ingested 
200 milligrams of surface soil containing the maximum concentration of copper detected on-site 
(8,300 ppm) for 1 day every week for 22 weeks (May through September, the warmer months of 
the year) over 5 years, the predicted exposure dose would be below the ATSDR Minimal Risk 
Level (MRL).  The MRL is an estimate of daily exposure to a contaminant below which adverse 
noncancer health outcomes are unlikely to occur.  Since the exposure dose for an older child 
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 playing on-site, even under highly conservative exposure assumptions, is below the MRL, 
noncancer health effects would not be expected.  See Appendix A for more information on the 
exposure dose calculations.   
 
The maximum detected concentration of PCBs for which documentation is available is 17,000 
ppm3.  This concentration is the average of two duplicate samples (19,000 ppm and 15,000 ppm) 
collected at a sampling station located near the northwestern corner of the on-site building 
(Paragon 1998).  It is very unlikely, however, that a trespasser would have had consistent contact 
with soil containing the highest concentration of PCBs at this particular location.  Rather, it is 
more likely that a trespasser at the former Polymerine site would contact surface soil with a 
range of PCB concentrations based on the distribution of contaminated soil within an area 
encompassing roughly 30,000 square feet located northwest, west and south of the on-site 
building (Figures 3 and 4).  A more reasonable and realistic scenario uses the average 
concentration of PCBs detected in surface soil in this area to reflect the range of contaminant 
concentrations that could have been contacted over time.  Assuming that an older child who 
trespassed regularly on the site could have been exposed to the average concentration of PCBs 
detected in surface soil (403 ppm) in this area through incidental ingestion, the estimated 
noncancer effects exposure dose (0.0001 mg/kg/day) is greater than the ATSDR Chronic MRL.  
The chronic MRL is based on adverse noncancer health effects observed in studies of monkeys 
that were exposed to 0.005 mg/kg/day (ATSDR 2008d).  Because the estimated noncancer 
effects exposure dose for an older child who trespassed in the above scenario is 50 times lower 
than the lowest exposure dose that resulted in adverse health effects in animal studies, noncancer 
health effects from past exposure to PCBs at the former Polymerine site are not expected even 
under the highly unlikely assumption that an individual frequently visited and/or played on the 
site itself.   
 
In order to evaluate the potential for carcinogenic health effects, exposure doses were estimated 
and compared to health guideline values for cancer.  The USEPA and the International Agency 
                                                 
3 According to several reports, an environmental site investigation conducted in 1993 detected a maximum 
concentration of PCBs in on-site soil and sediment of 49,000 ppm.  However, no documentation of this sample with 
its location and depth (surface or subsurface) could be located (Tighe and Bond 2008).   
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 for Research on Cancer (IARC) have classified PCBs as a probable human carcinogen based on 
sufficient evidence of carcinogenicity in animals and limited evidence in humans (ATSDR 
2008d).  Because it is difficult to show that a chemical causes cancer in humans, animal studies 
are used to identify chemicals that have the potential to cause cancer in humans.  PCBs do cause 
cancer in animals.  Thus, it is assumed that exposure to PCBs over a period of time might pose a 
health risk for humans.  The degree of risk depends on the intensity and frequency of exposure.   
 
Under similar and highly unlikely assumptions as for the above noncancer health effects, an 
unusual cancer risk would not be expected.  See Appendix A for more information on the 
exposure dose and cancer risk calculations for exposure via incidental ingestion.  Exposure of 
trespassers to contaminated subsurface soil is not expected due to its depth below ground 
surface.   
 
Under the same exposure conditions and assumptions described above, dermal exposure to the 
average concentration of PCBs detected in the contaminated section of the site results in an 
estimated noncancer effects exposure dose (0.00006 mg/kg/day) that is greater than the ATSDR 
Chronic MRL.  This indicates that it is possible that a trespassing older child could have been 
exposed via dermal contact to PCBs at a level that could have presented an increased risk of 
adverse noncancer health effects.  However, the estimated dermal exposure dose is more than 80 
times lower than the lowest exposure dose that resulted in adverse noncancer health effects in 
animal studies.  Therefore, noncancer health effects from past dermal exposure to PCBs at the 
former Polymerine site are not expected.  With regard to the potential for carcinogenic health 
effects, dermal exposure to the average concentration of PCBs detected in the contaminated 
section of the site under the same exposure conditions and assumptions as above is not expected 
to present an unusual cancer risk.  See Appendix B for more information on the exposure dose 
and cancer risk calculations for exposure via dermal contact.   
 
Although removal activities have been conducted at the former Polymerine site, concentrations 
of PCBs detected in surface soil still exceed the MDEP Method 1 standard of 2 ppm for category 
S-1 & GW-1 soil as evidenced by post-excavation confirmatory sampling.  As a result, additional 
remedial actions at the former Polymerine site are required in accordance with the MCP as 
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 specified in the Phase II CSA (Tighe & Bond 2009).  Furthermore, present and future ingestion 
of and dermal contact with contaminants in on-site surface soil by trespassers remain possible 
exposure pathways.  These exceedances are limited to two small, isolated areas located on the 
north and south sides of the on-site building (Figure 5).  The average concentration of PCBs in 
surface soil samples collected north of the building in an area encompassing roughly 400 square 
feet is 440 ppm (maximum concentration of 2,600 ppm) whereas the average concentration of 
PCBs in samples collected south of the building in an area encompassing about 200 square feet is 
50 ppm (maximum concentration of 150 ppm) (Tighe & Bond 2009).  These concentrations are 
similar to or less than those used above to estimate possible exposure doses.  Hence, based on 
that evaluation, health concerns would not be expected under current and future use conditions 
(i.e., as an industrial park).  See Appendices A and B for more information on the exposure dose 
and cancer risk calculations.   
B. Former Tallyrand Site 
Site Description 
The former Tallyrand site is located at 129 John Vertente Boulevard within the New Bedford 
Business Park in New Bedford.  The property is currently owned by the City of New Bedford 
(New Bedford 2008b; Roy F. Weston 1997).  Aerovox Corporation leases a portion of the 79-
acre site and uses the 136,500 square foot manufacturing building to produce AC film capacitors, 
which are used in applications such as electric motors, fluorescent light ballasts, and microwave 
ovens.  The remaining section of the property is currently vacant (Aerovox 2008; New Bedford 
2008b).   
 
The property is bordered to the north and west by Hobomock Swamp, to the east by Conrail 
Railroad tracks and Hobomock Swamp, and to the south by John Vertente Boulevard and 
Hobomock Swamp (SITEC Environmental 1996; Roy F. Weston 1997).  The nearest residence is 
located approximately 1,400 feet (0.27 miles) to the west along Demoranville Road in 
Dartmouth (MassGIS 2005).   
 
Site History 
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 The site was originally owned by the Acushnet Saw Mill Co. from 1895 to 1969.  Since then, it 
has changed ownership several times.  From 1969 to 1973, the site was owned by the New 
Bedford Industrial Foundation.  From 1973 to 1984, all of the corporations listed as either 
owners or lessees were involved in the manufacturing of polyvinyl chloride (PVC) pipe.  
Between 1978 and 1987, the site was owned by Tallyrand Chemicals, Inc. and Imex Polymers, 
Inc.  In 1992, the City of New Bedford acquired the property through foreclosure.  The site had 
been abandoned for several years and repeatedly vandalized.  Buildings associated with the 
former Tallyrand operations have since been demolished and a new building was constructed in 
1999 to accommodate Aerovox Corporation (New Bedford 2008b; VHB 1999a; Roy F. Weston 
1997).   
 
The following releases of oil and/or hazardous material have occurred at the former Tallyrand 
site and were reported to the MDEP under the MCP: 
 Release of transformer oil at an electrical transformer and pad in 1995 (RTN 4-0011419) 
 Release adjacent to the former mixing basin in 1999 (RTN 4-0014594) 
 Release beneath the former reactor building in 1999 (RTN 4-0014633) 
 
The release of transformer oil in 1995 occurred at the southern boundary of the former Tallyrand 
site and was likely a result of vandalism.  Consequently, the exact time of its occurrence is 
uncertain.  A six foot chain link security fence was installed to eliminate any further potential 
exposure via trespassing (SITEC Environmental 1996).   
 
Based on a review of available environmental data that was collected in response to the release 
of transformer oil, elevated concentrations of TPH and PCBs (primarily Aroclor-1260) that 
exceeded regulatory standards were detected in on-site soil in 1995 (MDEP 2008; SITEC 
Environmental 1996; Roy F. Weston 1997).  Exposure to contaminated subsurface soil would 
not be expected due to its depth below ground surface.  In addition, PCBs were found to have 
migrated along the surface of the shallow water table in an east-northeast direction (Roy F. 
Weston 1997).  See Table 2 for a summary of the maximum concentrations of contaminants 
detected in on-site soil that exceeded comparison values.    
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 In October 1997, the USEPA completed a limited removal action at the site, excavating PCB-
contaminated soil and disposing of it in a hazardous waste landfill.  Excavation was conducted in 
areas of soil with total PCB concentrations exceeding the site-specific USEPA action level of 10 
ppm.  Excavation was continued to depths where PCB concentrations were less than the action 
level or until the water table was encountered (approximately 4.5 feet below the ground surface).  
Excavated areas were backfilled with clean fill (Roy F. Weston 1997).  As a result of the 
removal action, concentrations of PCBs in surface soil (0-3 inches) are expected to meet the 
USEPA action level of 10 ppm.  They may, however, exceed the ATSDR CREG of 0.4 ppm 
(ATSDR 2008a).  PCB concentrations of up to 4,500 ppm remain on-site in subsurface soil at 
depths of 7 feet or greater or below the water table in a small portion of the site (Roy F. Weston 
1997).  Since the USEPA removal action focused on PCB contamination only, concentrations of 
TPH remaining in on-site soil are unknown but are expected to have been reduced.  In August 
2008, the MDEP determined that no further action was required for this release site (MDEP 
2009).   
 
Although the two releases that were reported to the MDEP in 1999 were separate and discrete, 
both involved creolin (a coal tar derivative).  Elevated concentrations of semi-volatile organic 
compounds (SVOCs) and TPH were detected in subsurface soil at the former mixing basin 
release area and elevated concentrations of TPH were detected in subsurface soil at the former 
reactor building release area.  The maximum concentrations of the SVOC 2-methylnapthalene 
(3,700 mg/kg) and TPH (20,000 mg/kg) detected at the former mixing basin release site 
exceeded MDEP Method 1 standards for category S-1 & GW-1 soil.  The maximum 
concentration of TPH (2,100 mg/kg) detected at the former reactor building release site also 
exceeded MDEP Method 1 standards for category S-1 & GW-1 soil (VHB 1999a).  Since all 
elevated concentrations were detected in subsurface soil (3-5 feet below ground surface), 
exposure to contaminants from either of these releases is not expected to occur either in the past, 
present or future due to its depth below the ground surface.   
 
A total of approximately 170 cubic yards of creolin-impacted soil was excavated from the 
mixing basin release site and approximately 50 cubic yards was excavated at the reactor building 
release site.  All excavated soil was disposed off-site (VHB 1999a,b).  As a result of the 
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 excavation, contaminant concentrations in both areas are expected to meet MDEP soil standards.  
Furthermore, Class A-2 Response Action Outcomes (RAOs) were issued by the MDEP in 2005 
for both RTNs (VHB 1999a).  This indicates that remedial work was completed at the former 
mixing basin and former reactor building, a permanent solution has been achieved and, although 
contamination has not yet been reduced to background levels, a level of “no significant risk” of 
harm to health, safety, public welfare and the environment has been achieved for these two areas 
(MDEP 2008).   
 
Site Status 
Prior to the completion of remediation in 1997 of contaminated soil from the release of 
transformer oil (RTN 4-0011419), it is possible that a trespasser at the former Tallyrand site may 
have been exposed through incidental ingestion of or dermal contact with PCBs (mainly Arcolor-
1242 and Aroclor-1260) and TPH detected in on-site soil at levels above comparison values4.  
However, it is important to consider that comparison values are based on a residential exposure 
scenario, and it is unlikely that a trespasser would have had contact with contaminated soil for a 
frequency and duration of time comparable to a resident.  It is particularly unlikely for several 
reasons.  First, the area that was contaminated consisted of a very small, isolated portion of the 
property, encompassing approximately 40 feet by 24 feet of the 79-acre property (0.03%) (Figure 
6).  Second, the former Tallyrand facility is centrally located within the New Bedford Business 
Park.  Third, access to the former Tallyrand site is generally limited to the road as it is bordered 
by Hobomock Swamp in all directions with the nearest residence approximately one-third of a 
mile away.  Observations made by the MDPH (i.e., CAP staff) during a visit to the former 
Tallyrand site confirmed these conditions.   
 
Although highly unlikely, the potential exposure was estimated for an older child who may have 
inadvertently ingested surface soil containing the average concentration of total PCBs detected in 
on-site soil (0-6 inches) in the area of contamination (887 ppm) for 1 day every month for 5 
months (May through September, the warmer months of the year) over 5 years.  The estimated 
noncancer effects exposure dose (0.00005 mg/kg/day) is greater than the ATSDR Chronic MRL 
                                                 
4 Due to the lack of appropriate health-based comparison values, TPH was not evaluated further.   
20 
 (0.00002 mg/kg/day).  As previously noted, the chronic MRL for PCBs is based on adverse 
noncancer health effects observed in studies of monkeys that were exposed to 0.005 mg/kg/day 
(ATSDR 2008d).  Because the estimated noncancer effects exposure dose for an older child who 
trespassed in the above scenario is 100 times lower than the lowest exposure dose that resulted in 
adverse noncancer health effects in animal studies, noncancer health effects from past exposure 
to PCBs at the former Tallyrand site are not expected.  In addition, using the same exposure 
assumptions, an unusual cancer risk would not have been expected.  See Appendix C for more 
information on the exposure dose and cancer risk calculations.  As previously stated, exposure of 
trespassers to contaminated subsurface soil would not be expected due to its depth below ground 
surface.   
 
Under the same exposure conditions and assumptions described above, dermal exposure to the 
average concentration of total PCBs detected in on-site surface soil in the contaminated area (887 
ppm) results in an estimated noncancer effects exposure dose (0.00003 mg/kg/day) that is greater 
than the ATSDR Chronic MRL.  However, the estimated noncancer effects (dermal exposure) 
dose for an older child who trespassed and contacted the average concentration of total PCBs 
detected on-site in the above scenario is more than 160 times lower than the lowest exposure 
dose that resulted in adverse health effects in animal studies.  Therefore, noncancer health effects 
from dermal exposure to surface soil containing PCBs prior to remediation at the former 
Tallyrand site would not have been expected.  With regard to the potential for carcinogenic 
health effects, dermal exposure to the average concentration of total PCBs detected in on-site 
surface soil under the same exposure conditions and assumptions as above would not be 
expected to present an unusual cancer risk.  See Appendix D for more information on the 
exposure dose and cancer risk calculations.   
 
As a result of removal activities, concentrations of PCBs in surface soil are not expected to 
exceed the USEPA action level of 10 ppm.  However, it is possible that PCB concentrations 
could still exceed health-based comparison values.  Under the same exposure conditions and 
assumptions described above, present and future ingestion of and dermal contact with PCBs in 
on-site surface soil by trespassers are not expected to result in adverse non-cancer or cancer 
health effects.  See Appendices C and D for more information on the exposure dose and cancer 
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 risk calculations for exposure via ingestion and dermal contact, respectively.  In addition, the 
possibility that trespassers could come into contact with contaminated surface soil has been 
minimized since access to the former Tallyrand site is now restricted by a chain link security 
fence and monitored by closed circuit TV.  Exposure of trespassers to contaminated subsurface 
soil remaining at the site would not be expected due to its depth below ground surface.   
 
It should be noted that there is no completed groundwater exposure pathway for any of the three 
releases that occurred at the former Tallyrand site because groundwater at the site is not used for 
drinking water.  The on-site building and the surrounding neighborhoods are served by the City 
of New Bedford Water Department (VHB 1999a).   
 
Although groundwater at the former Tallyrand site could be a potential source of vapor intrusion 
for the on-site building (a private business), this potential exposure pathway was eliminated for 
nearby residents in the past, present and future due to the distance to the nearest residences 
(VHB 199a; ITRC 2007; USEPA 2002).  Therefore, vapor intrusion as a potential exposure 
pathway was not evaluated further in this health consultation.   
C. Former Polaroid Site 
Site Description 
The former Polaroid site is located at 100 Duchaine Boulevard within the New Bedford Business 
Park in New Bedford.  In January 2008, the property was acquired by Konarka Technologies Inc. 
for the manufacture of thin-film photovoltaic material (Cohen 2008).  The 128-acre property 
includes manufacturing buildings, a power plant, a wastewater treatment plant (WWTP), asphalt 
parking areas, undeveloped wooded and wetland areas, and a pond (GEI 2001; New Bedford 
2008c).  
 
The site is bordered to the north by commercial and industrial properties, to the east by a 
residential community referred to as Pine Hill Acres, to the west by Conrail Railroad tracks, and 
to the west and south by the Acushnet Cedar Swamp State Reservation.  The nearest residence to 
the property is located approximately 275 feet to the east along Ridgewood Road (MassGIS 
2005; Roux Associates 2004).   
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Site History 
Prior to construction of the Polaroid facility in 1969-1970, the land consisted of undeveloped 
farmland and wetlands (Roux Associates 2004).  Polaroid owned the property and operated a 
high resolution media manufacturing division and a photographic negative manufacturing 
division until 2006, when MultiLayer Coating Technologies, LLC (formerly Polaroid Contract 
Coating) was established.  During this time, the on-site WWTP served all buildings on the 
property and treated the wastewater generated facility-wide.  The on-site power plant supplied 
the facility with steam and cooling water (Watermill Group 2006; GEI 2002).   
 
In November 1993, the MDEP was notified of a reportable release or threat of release of fuel oil 
#6 and TPH from an underground storage tank.  The RTN 4-0010113 was assigned.  In January 
1994, a Class B-1 RAO was issued for this release, indicating that remedial actions were not 
conducted because a level of “no significant risk” of harm to health, safety, public welfare or the 
environment already existed.  Additionally, no “activity and use limitation” on the property was 
necessary to ensure the existence or maintenance of this level (MDEP 2009, 2008a).  Thus, no 
further analysis of past, present or future exposures related to this release site is required.   
 
In June 2001, MDEP was notified of a release of sulfuric acid from an above-ground storage 
tank in the vicinity of the WWTP on the western side of the property.  The RTN 4-0016316 was 
assigned (MDEP 2009).   An Immediate Response Action Completion Report, Phase I Initial Site 
Assessment Report, Phase II Comprehensive Site Assessment and Phase III Comprehensive 
Remedial Action Alternatives Report, and a Phase IV Remedy Implementation Plan have been 
completed for this site (Roux Associates 2006).  The sulfuric acid impacted soil within an area 
encompassing approximately 1,600 square feet by reducing the pH to less than 4.0 and to less 
than 2.0 in some smaller areas.  Soil contamination was detected at depths ranging from two to 
ten feet below ground surface.  The pH of groundwater in the immediate down-gradient direction 
was reduced as a result of leaching of sulfuric acid from affected soil by rainwater in the 
unpaved portions of the site (Roux Associates 2004).  Risk characterization conducted as part of 
the Phase II and Phase III found no impacts to the surface water and sediment in the wetlands 
that border the WWTP on all four sides (Roux Associates 2005).  Remedial activities, including 
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 excavation and disposal of 347 tons of contaminated soil, were implemented in 2005.  Sampling 
confirmed that the pH of the soil remaining at the site is generally within the range of 4 to 7, 
which is considered background for the area.  In 2006, a Class A-1 RAO was issued for this 
release, indicating that remedial work was completed, a permanent solution was achieved, the 
source of contamination was adequately removed allowing for concentrations to approach 
background, and a level of “no significant risk” of harm to health, safety, public welfare, and the 
environment exists currently and in the foreseeable future (Roux Associates 2006).   
 
Polaroid and MultiLayer Coating Technologies were both classified as a Large Quantity 
Generator (LQG) under RCRA (Generator Identification MAD058060476).  LQG facilities 
generate over 1,000 kg of hazardous waste per month (Roux Associates 2004).  Hazardous waste 
generated at the facility included methanol, silver compounds, and nitrate compounds (USEPA 
2008).  An inspection conducted by the MDEP in 1997 cited a violation whereby storage tanks 
containing hazardous waste lacked secondary containment (MDEP 1997).  However, an 
inspection conducted more recently in 2002 found no violations relative to the management of 
hazardous waste (MDEP 2002b).   
 
A Draft Air Quality Operating Permit (Application Number 4V95157) was issued by the MDEP 
for the Polaroid facility in 2004.  The permit identifies equipment and processes that produce air 
emissions as well as any pollution control devices that are in place.  Criteria pollutants for which 
emission limits and restrictions are set in the permit include nitrogen oxides (NOx), carbon 
monoxide (CO), particulate matter (PM), sulfur dioxide (SO2), sulfur in fuel, and VOCs.  
Additional requirements in the permit include monitoring, testing, and recordkeeping as well as a 
special term and condition, which states that the facility is subject to Subpart JJJJ of 40 CFR 63 
since it is a major stationary source of Hazardous Air Pollutants (HAPs) (MDEP 2004a).  This 
subpart establishes emission standards specifically for paper and other web coating lines and 
involves technology-based standards that use maximum achievable control technologies.   
 
A review of data reported in the USEPA’s Toxics Release Inventory (TRI) was conducted to 
gain additional information regarding the types and amounts of pollutants emitted from the 
facility, particularly HAPs.  The TRI is a reporting system that estimates the annual releases of 
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 toxic chemicals to the environment.  The system evolved from the Emergency Planning and 
Community Right-to-Know Act.  Businesses are required to report the locations and quantities of 
chemicals stored on a site to state and local agencies to help communities prepare to respond to 
potential chemical spills and emergency releases (USEPA 2008).  Although TRI annual release 
estimates cannot be used to specifically evaluate whether individuals living near the former 
Polaroid facility were actually at risk of exposure to air emissions, the information can be helpful 
when evaluating the pattern of disease in the nearby area and the possibility that environmental 
factors may play a role.   
 
Review of available TRI data for the former Polaroid facility for the years 1988-2006 indicates 
that methanol, methyl ethyl ketone (MEK, also known as 2-butanone) and hydrochloric acid 
have been emitted to air from the facility.  All three are classified as HAPs.  None have been 
classified with respect to carcinogenicity (USEPA 2000a,b; ATSDR 2008c).  The major health 
concerns if long-term exposure to methanol were to occur would include headaches, dizziness, 
insomnia, nausea, gastric disturbances, conjunctivitis, and blurred vision (USEPA 2000a).  
Limited information is available on the health effects from long-term exposure to MEK but may 
include mild respiratory irritation of the nose and throat.  It should be noted that MEK has a 
sharp, but sweet odor that may be smelled even at low concentrations (USEPA 2000b; ATSDR 
1992).  If long-term exposure to hydrochloric acid were to occur, major health concerns may 
include gastritis, chronic bronchitis, dermatitis, and photosensitization (USEPA 2000c).  It 
should be noted that when such health effects do occur, it is typically in an occupational setting 
where the concentration level would be higher and the duration of exposure longer than would be 
expected for nearby residents.   
 
Stack emissions of methanol were highest in the late 1980s and early 1990s.  The maximum 
stack emission of methanol (44,900 pounds) was reported in 1990.  Annual stack emissions of 
methanol have generally decreased since then, with 12,000 pounds released in 2006.  Fugitive 
emissions (emissions from sources other than stacks or vents, such as equipment leaks and 
evaporative losses) of methanol have generally increased from a minimum annual emission of 
100 pounds from 1989 to 1993 to 1,800 pounds in 2004, with a spike of 4,700 pounds in 2005.  
MEK was last released from the Polaroid facility in 2003, at which time fugitive emissions were 
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 3,900 pounds and stack emissions were 1,400 pounds.  Hydrochloric acid was also reported 
historically, but not since 1995 (see Table 3).   
 
Since 1990, air emission violations were cited on two occasions at the Polaroid facility.  One 
violation in 1990 was observed based on the density and opacity of the smoke emitted from a 
stack and the other violation in 2004 was observed based on soot fallout in the Pine Hill Acres 
neighborhood.  Reportedly, the cause of both of these violations was promptly identified by 
Polaroid and corrective actions were taken (MDEP 1990, 2004b; Polaroid 1990, 2004).  Air 
compliance evaluations that were conducted in 1997, 2002 and 2007 by the MDEP, Bureau of 
Waste Prevention found the facility to be in compliance based upon observation of visible 
emissions, on-site inspections, and facility records and logs (MDEP 1997, 2002b, 2007).  It 
should be noted that no ambient air sampling data are available for the neighborhoods in the 
immediate vicinity of the facility.   
 
Site Status 
With regards to the release of sulfuric acid near the WWTP in 2001, no past, present or future 
exposure pathway is complete due to the depth below ground surface (2-10 feet) at which 
contamination was detected.  Remedial activities included the excavation and disposal of 
contaminated soil.  Exposure to impacted soil remaining at the site is not expected to occur due 
to its presence at depths greater than seven feet below ground surface.  The MDEP considers the 
remediation of this release to be complete as indicated by the Class A-1 RAO that was issued 
(Roux Associates 2006).   
 
The groundwater at the former Polaroid facility is not used for drinking water.  The on-site 
building is served by the City of New Bedford Water Department.  No private drinking water 
wells are located within 500 feet of the site (GEI 2002).  As a result, there is no completed 
groundwater exposure pathway in the past, present or future.   
 
Prior to the excavation and disposal of contaminated soil, it is possible that the indoor air of the 
WWTP building could have been affected by vapor intrusion of hydrogen sulfide or hydrogen 
gas which could be generated via reaction of sulfuric acid with organic materials and cast iron 
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 piping, respectively (Roux Associates 2004).  Therefore, the potential exists that on-site 
employees may have been exposed in the past to contaminants via inhalation of indoor air that 
was affected by vapor intrusion.  However, exposure of nearby residents to contaminants via 
vapor intrusion is not expected in the past, present or future.   
 
The results of the air compliance evaluations conducted at the former Polaroid facility indicate 
that the requirements and limitations set forth in the Draft Air Quality Operating Permit have 
been met.  Although violations were cited on two occasions since 1990, corrective actions were 
promptly taken by Polaroid.   
 
On the basis of the TRI data reviewed, past opportunities for exposure to ambient air emissions 
from the former Polaroid facility were a possibility for nearby residents when the facility was in 
operation.  Stack and fugitive emissions of methanol may have resulted in exposure opportunities 
in ambient air.  While MEK is no longer emitted at the facility, it is possible that stack and 
fugitive emissions may have resulted in potential exposure prior to 2004.  Likewise, it is possible 
that stack emissions of hydrochloric acid may have resulted in potential exposure prior to 1996.  
Since there are no historical ambient air data available for the former Polaroid facility or the 
surrounding neighborhoods, it is difficult to evaluate whether facility emissions may have 
resulted in health impacts.  As previously mentioned, it is primarily occupational exposure to 
these chemicals that have been attributed to adverse health effects.  Such workplace settings 
typically involve concentration levels that would be higher and exposure durations that would be 
longer than those experienced by nearby residents. However, since MEK is a respiratory irritant, 
the MDPH examined available hospital discharge data for asthma in the area surrounding the 
former Polaroid facility to assess whether the number of asthma hospitalizations was occurring 
as expected based on the statewide experience.   
 
Asthma is a chronic inflammatory pulmonary disorder that is characterized by reversible 
obstruction of the airways.  Causes of asthma are unknown; however, episodes of asthma 
(asthma attacks) can be triggered by certain environmental pollutants such as air pollution, mold, 
pets/pet dander, and dust mites.  A number of studies have reported links between being exposed 
to air pollution and asthma.  The outdoor air pollutants most commonly linked to asthma attacks 
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 are particulate matter and ozone.  Reducing exposure to these pollutants can help prevent 
symptoms.   
 
The Massachusetts Division of Health Care Finance and Policy (DHCFP) collects individual-
level information on all patients who are discharged from hospitals in Massachusetts.  The 
collection of data is mandated by regulation 114.1 CMR 17.00, Requirement for the Submission 
of Hospital Case Mix and Charge Data.  Each hospitalization in Massachusetts is coded using the 
International Classification of Disease 9th Revision codes (ICD-9).  The hospital discharge 
database was queried using the specific ICD-9 code for asthma, where asthma was the primary 
cause of hospitalization.   
 
It is important to note that there are some limitations to the data on asthma hospitalizations.  
First, the data are only provided at the level of city/town or zip code.  This makes it impossible to 
determine if one specific neighborhood has more asthma hospitalizations than another.  As a 
result, an aggregate analysis of hospital discharge data was conducted at the zip code level.  
Second, the data reflect the numbers of hospitalizations reported, not the number of individuals 
hospitalized.  For example, when the database is used to identify the number of asthma 
hospitalizations in a particular zip code during a specified time period, it would count one 
individual hospitalized ten times the same number of times as it would count ten individuals each 
hospitalized once.  Third, the hospital discharge data are limited to inpatient hospitalizations with 
a minimum stay requirement.  The data do not include individuals who do not receive medical 
care or who are not hospitalized, including those who die in emergency rooms, in nursing homes, 
or at home without being admitted to a hospital, as well as those treated in outpatient settings.  It 
is important to keep this in mind when interpreting the asthma hospitalization data presented 
here.   
 
The hospital discharge database was queried for asthma hospitalizations of residents of zip code 
02745 in New Bedford, which encompasses approximately 10 square miles (Figure 7).  These 
data were examined to determine how many times individuals were hospitalized with asthma 
each year during the four-year period of 2000 through 2003.  This time period reflects the most 
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 complete data available through 2003, after which point MEK was no longer emitted from the 
former Polaroid facility.   
 
The statistic reported is the Standardized Hospitalization Ratio (SHR), which was calculated as 
the ratio of the number of hospitalizations observed in zip code 02745 to the number that would 
be expected if the population of the zip code had the same age-specific hospitalization rates as 
the statewide population, multiplied by 100.  [Note that the SHR is not meaningful for the entire 
state; by definition the result is always 100.]  An SHR of more than 100 indicates that the 
number of hospitalizations within the zip code was higher than expected compared to the 
statewide experience and an SHR of less than 100 indicates that the number of hospitalizations 
was less than expected compared to Massachusetts.  A 95% confidence interval (CI) was 
calculated to determine if the observed number of hospitalizations is “statistically significantly 
different” from the expected number, meaning that there is less than a 5% percent chance that the 
observed difference (either increase or decrease) in the number of hospitalizations is the result of 
random fluctuation.   
 
Table 4 provides a summary of the hospital discharge data for asthma hospitalizations in zip 
code 02745 for each year from 2000 to 2003 as well as the entire 4-year period.  A total of 154 
asthma hospitalizations were reported in zip code 02745 during 2000-2003 compared to 
approximately 133 expected based on the statewide experience; this difference was of borderline 
statistical significance (SHR = 115, 95% CI = 98-135).  With the exception of one year (2000) 
during which the number of asthma hospitalizations was statistically significantly lower than 
expected, the number of asthma hospitalizations in any given year during 2000-2003 was 
elevated for residents of this zip code compared to the statewide experience.  The elevations, 
however, were not statistically significant except during 2003 when 58 asthma hospitalizations 
were observed and about 39 were expected (SHR = 150, 95% CI = 114-194).  Overall, there does 
not appear to be a relationship between the level of emissions of MEK from the former Polaroid 
facility and the number of asthma hospitalizations within zip code 02745 over the four-year 
period 2000-2003.  The level of emissions of MEK generally decreased over this time period and 
a corresponding decrease in the number of asthma hospitalizations was not observed.   
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 For more information regarding the air emissions at the former Polaroid facility, the Bureau of 
Waste Prevention at the MDEP Southeast Region may be contacted at 508-946-2700.   
V. Methods for Analyzing Cancer Incidence 
A. Case Identification/Definition 
As part of this investigation, the CAP reviewed cancer incidence data available from the MCR 
for the following six cancer types in New Bedford CTs 6501.01 and 6501.02: cancers of the 
bladder, breast, kidney/renal pelvis, liver/intrahepatic bile duct, lung and bronchus, and prostate.  
Area residents requested that these specific types of cancer be evaluated.  The 10-year period 
from 1996-2005 was evaluated and constituted the time period for which the most recent and 
complete cancer incidence data were available at the time of this report5.  The MCR is a division 
within the MDPH Bureau of Health Information, Statistics, Research, and Evaluation (BHISRE).  
It is a population-based surveillance system that has been monitoring cancer incidence in the 
Commonwealth since 1982.  All new diagnoses of invasive cancer, as well as certain in situ 
(localized) cancers, among Massachusetts residents are required by law to be reported to the 
MCR within 6 months of the date of diagnosis (M.G.L. c.111. s 111b).  The MCR also gathers 
background information (e.g. gender, age, and address at time of diagnosis) on each individual 
reported.  This information is kept in a confidential database.  Data are collected daily and 
reviewed for accuracy and completeness on an annual basis.  Due to the high volume of data 
collected and the 6-month period between diagnosis and required reporting, the most current 
registry data that are complete will be a minimum of 2 years prior to the current date.   
 
The term “cancer” is used to describe a variety of diseases associated with abnormal cell and 
tissue growth.  Epidemiologic studies have revealed that different types of cancer are individual 
diseases with separate causes, risk factors, characteristics, and patterns of survival.  Cancers are 
classified by the location in the body where the disease originated (the primary site) and the 
tissue or cell type of the cancer (histology).  Therefore, each of the cancer types reviewed in this 
report was evaluated separately.  Cancers that occur as the result of the metastasis or the spread 
                                                 
5 The data summarized in this report are drawn from data entered into the MCR before March 6, 2009.  The numbers 
presented in this report may change slightly in future reports, reflecting late reported cases, address corrections, or 
other changes based on subsequent details from reporting facilities.   
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 of a primary site cancer to another location in the body are not considered as separate cancers 
and, therefore, are not included in this analysis.   
 
It should be noted that the MCR database may occasionally contain duplicate reports of 
individuals diagnosed with cancer.  Duplicate cases are additional reports of the same primary 
site cancer diagnosed in an individual by another health-care provider.  In New Bedford, no 
duplicate reports were identified during the years 1996-2005.  However, reports of individuals 
with multiple primary site cancers were included as separate cases in the analysis in this report.  
A multiple primary cancer case is defined by the MCR as a new cancer in a different location in 
the body, or a new cancer of the same histology as an earlier cancer, if diagnosed in the same 
primary site more than two months after the initial diagnosis (MCR 2003).  Therefore, duplicate 
reports of an individual diagnosed with cancer would have been removed from the analysis 
whereas individuals who were diagnosed with more than one primary site cancer were included 
as separate cases.   
B. Calculation of a Standardized Incidence Ratio (SIR) 
To assess the incidence of cancer in a community or CT, a statistic called the standardized 
incidence ratio (SIR) is calculated using data from the MCR.  Specifically, an SIR is the ratio of 
the observed number of cancer diagnoses in an area to the expected number of diagnoses 
multiplied by 100.  Age-specific statewide incidence rates are applied to the population 
distribution of a community to calculate the number of expected cancer diagnoses.  The SIR is a 
comparison of the number of diagnoses in the specific area (i.e., community or CT) to the 
number of expected diagnoses based on the statewide rate.  Comparison of SIRs between 
communities or CTs is not possible because each of these areas has different population 
characteristics.   
 
To calculate an SIR, it is necessary to obtain accurate population information.  Population is 
interpolated based on 1990 and 2000 U.S. census data for the community of interest (U.S. DOC 
1990, 2000).  Midpoint population estimates are calculated for each time period evaluated.  To 
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 estimate the population between census years, an assumption is made that the change in 
population occurs at a constant rate throughout the ten-year interval between each census6.   
 
A CT is a smaller geographic subdivision of a city or town designated by the U.S. Census 
Bureau.  Because age group and gender-specific population information is necessary to calculate 
cancer incidence rates, the CT is the smallest geographic area for which cancer rates can be 
accurately calculated.  CTs usually contain between 1,500 and 8,000 persons and are designed to 
be homogenous with respect to population characteristics (U.S. DOC 2000).   
 
SIRs were not calculated for some cancer types due to the small number of observed cases.  It is 
standard MDPH/BHISRE policy not to calculate rates with fewer than five observed diagnoses 
due to the instability of the rate.  However, the expected number of diagnoses was calculated 
during each time period, and the observed and expected numbers of diagnoses were compared to 
determine whether excess diagnoses of cancer were occurring.   
C. Interpretation of a Standardized Incidence Ratio (SIR) 
An SIR is an estimate of the occurrence of cancer in a population relative to what might be 
expected if the population had the same cancer experience as a larger comparison population 
designated as "normal" or average.  Usually, the state as a whole is selected to be the comparison 
population.  Using the state of Massachusetts as a comparison population provides a stable 
population base for the calculation of incidence rates.   
 
Specifically, an SIR of 100 indicates that the number of cancer diagnoses observed in the 
population being evaluated is equal to the number of cancer diagnoses expected in the 
comparison or “normal” population.  An SIR greater than 100 indicates that more cancer 
diagnoses occurred than expected and an SIR less than 100 indicates that fewer cancer diagnoses 
occurred than expected.  Accordingly, an SIR of 150 is interpreted as 50% more diagnoses than 
the expected number; an SIR of 90 indicates 10% fewer diagnoses than expected.   
 
                                                 
6 Using slightly different population estimates or statistical methodologies, such as grouping ages differently or 
rounding off numbers at different points during calculations, may produce slightly different results.   
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 Caution should be exercised, however, when interpreting an SIR.  The interpretation of an SIR 
depends on both the size and the stability of the SIR.  Two SIRs may have the same size but not 
the same stability.  For example, an SIR of 150 based on four expected diagnoses and six 
observed diagnoses indicates a 50% excess in cancer, but the excess is actually only two 
diagnoses.  Conversely, an SIR of 150 based on 400 expected diagnoses and 600 observed 
diagnoses represents the same 50% excess in cancer, but because the SIR is based upon a greater 
number of diagnoses, the estimate is more stable.  It is very unlikely that 200 excess diagnoses of 
cancer would occur by chance alone.  As a result of the instability of incidence rates based on 
small numbers of diagnoses, SIRs are not calculated when fewer than five diagnoses are 
observed for a particular cancer type. 
 
To help interpret or measure the stability of an SIR, the statistical significance of an SIR can be 
assessed by calculating a 95% confidence interval (CI) to determine if the observed number of 
diagnoses is “statistically significantly different” from the expected number or if the difference 
may be due solely to chance (Rothman and Boice 1982).  Specifically, a 95% CI is the range of 
estimated SIR values that has a 95% probability of including the true SIR for the population.  If 
the 95% CI range does not include the value 100, then the study population is significantly 
different from the comparison or “normal” population.  “Significantly different” means there is 
less than a 5% percent chance that the observed difference (either increase or decrease) in the 
rate is the result of random fluctuation in the number of observed cancer diagnoses. 
 
For example, if a confidence interval does not include 100 and the interval is above 100 (e.g., 
105-130), then there is a statistically significant excess in the number of cancer diagnoses.  
Similarly, if the confidence interval does not include 100 and the interval is below 100 (e.g., 45-
96), then the number of cancer diagnoses is statistically significantly lower than expected.  If the 
confidence interval range includes 100, then the true SIR may be 100.  In this case, it cannot be 
determined with certainty whether the difference between the observed and expected number of 
diagnoses reflects a real cancer increase or decrease or is the result of chance.  It is important to 
note that statistical significance alone does not necessarily imply public health significance.  
Determination of statistical significance is just one tool used to interpret cancer patterns. 
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 In addition to the range of the estimates contained in the confidence interval, the width of the 
confidence interval also reflects the stability of the SIR estimate.  For example, a narrow 
confidence interval (e.g., 103-115) allows a fair level of certainty that the calculated SIR is close 
to the true SIR for the population.  A wide interval (e.g., 85-450) leaves considerable doubt about 
the true SIR, which could be much lower than or much higher than the calculated SIR.  This 
would indicate an unstable statistic.  Again, due to the instability of incidence rates based on a 
small numbers of diagnoses, statistical significance is not assessed when fewer than five 
diagnoses are observed.   
D. Determination of Geographic Distribution of Cancer Diagnoses 
Address at the time of diagnosis was mapped for each individual diagnosed with one of the six 
cancer types in New Bedford from 1996 to 2005 using a computerized geographic information 
system (GIS) (ESRI 2009).  This allowed assignment of CT location for each diagnosis as well 
as an evaluation of the spatial distribution of individual diagnoses at a smaller geographic level 
within a CT (i.e., neighborhoods).  The geographic pattern was assessed by qualitatively 
evaluating the point pattern of diagnoses for each of the six cancer types within CTs 6501.01 and 
6501.02.  This evaluation included consideration of the population density variability through the 
use of GIS-generated population density overlays.  Due to community concerns related to the 
former Polymerine, Tallyrand and Polaroid sites, particular attention was paid to the spatial 
pattern of cancer in the vicinity of these sites (See Figure 2).  In instances where the address 
information from the MCR was incomplete, that is, did not include specific streets or street 
numbers, efforts were made to research those individuals diagnosed with cancer (e.g., by using 
telephone books issued within two years of an individual's diagnosis or searching files via the 
Registry of Motor Vehicles).   
 
The MDPH is bound by law not to make public the names or any other information (e.g., place 
of residence) that could personally identify individuals with cancer whose diagnoses have been 
reported to the MCR (M.G.L. c.111. s. 24A).  Therefore, for confidentiality reasons, it is not 
possible for the MDPH to release maps showing the locations of individuals diagnosed with 
cancer in public reports.  However, a summary of the evaluation of geographic distribution with 
any notable findings is presented in this report.   
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 E. Evaluation of Cancer Risk Factor Information 
In those instances where the incidence rate of a particular cancer type was higher than expected, 
available information from the MCR related to risk factors for cancer development was reviewed 
and compared to known or established incidence patterns for the six cancer types evaluated in 
this report.  This information is collected for each individual at the time of cancer diagnosis and 
includes age at diagnosis, stage of disease, tobacco history and occupation.  One or even several 
factors acting over time can be related to the development of cancer.  For example, tobacco use 
has been linked to bladder, kidney/renal pelvis, lung and bronchus, and pancreatic cancers.  
Other risk factors for various cancer types may include lack of crude fiber in the diet, high fat 
consumption, excessive alcohol consumption, and reproductive history.  Heredity, or family 
history, is an important risk factor for several cancers.  To a lesser extent, some occupational 
exposures, such as jobs involving contact with asbestos, have been shown to be carcinogenic.  
Environmental contaminants have also been associated with certain types of cancer.  This 
information was evaluated to compare known or established risk factor patterns, as reported in 
the medical and epidemiological literature for particular cancer types, to risk factor information 
for individuals diagnosed in CTs 6501.01 and 6501.02, to assess whether any unexpected 
patterns exist.  However, information about personal risk factors that might include family 
history, hormonal events, diet, and other factors that may also influence the development of 
cancer is not collected by the MCR; therefore, it was not possible to consider their contributions 
to cancer in this investigation.   
VI. Results of Cancer Incidence Analysis 
The following sections present cancer incidence rates for CTs 6501.01 and 6501.02 in the 
community of New Bedford during the 10-year time period 1996-2005.  To evaluate possible 
trends over time as compared to the statewide cancer experience, these data were analyzed by 
two smaller time periods, 1996-2000 and 2001-2005.  Tables 5 and 6 summarize cancer 
incidence data for CT 6501.01 while Tables 7 and 8 summarize cancer incidence data for CT 
6501.02.  The expected number of diagnoses was calculated during each time period and for 
each CT, and the observed and expected numbers of diagnoses were compared to determine 
whether excess numbers of cancer diagnoses were occurring.  As previously mentioned, SIRs 
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 were not calculated for some cancer types due to the small number of observed cases (less than 
five).   
A. Cancer Incidence in CT 6501.01 
Review of cancer incidence rates in CT 6501.01 showed that cancer incidence occurred as or 
below expected for two of the six cancer types evaluated (see Tables 5 and 6).  In each of the two 
time periods evaluated, the incidence of bladder and  breast cancer in both genders was either 
less than or about as expected when compared to the statewide cancer experience.  For these two 
cancer types, if the number of observed diagnoses was greater than the number expected, the 
difference was based on one or two diagnoses and in no instance was the difference statistically 
significant.  Furthermore, the geographic and temporal distribution of diagnoses for both of these 
cancer types was reviewed.  Although some diagnoses did occur among individuals whose 
residences at the time of diagnosis were located within the Briarwood Development, the spatial 
distribution for each cancer type generally followed the population density pattern within the CT.  
In addition, the temporal distribution of diagnoses was not unusual.  The incidence rates of the 
remaining four types of cancer – kidney/renal pelvis, liver/intrahepatic bile duct, lung and 
bronchus, and prostate – showed somewhat greater variability.  It is important to note, however, 
that no elevations in incidence for these cancer types were statistically significant.  The incidence 
of these four cancer types is discussed further below.   
1. Kidney/Renal Pelvis Cancer Incidence 
In CT 6501.01, the incidence of kidney/renal pelvis cancer in males and females combined was 
elevated during 1996-2000 (8 diagnoses observed compared to approximately 4 expected) but 
was about as expected based on the statewide experience during 2001-2005.  A separate 
evaluation by gender revealed that the incidence of kidney/renal pelvis cancer among males was 
about as expected in both of the two time periods evaluated.  Among females, however, the 
incidence was slightly elevated during 1996-2000 (5 diagnoses observed compared to 
approximately 2 expected) but was about as expected during 2001-2005.  It is important to note 
that where the numbers of observed diagnoses were greater than expected, the differences were 
not statistically significant.   
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 Available risk factor information was reviewed for those individuals in CT 6501.01 diagnosed 
with kidney/renal pelvis cancer between 1996 and 2000.  According to the American Cancer 
Society (ACS), the average age of individuals diagnosed with kidney/renal pelvis cancer is 65 
years.  With the exception of Wilm’s tumor, which is most common in children, kidney/renal 
pelvis cancer is very uncommon under the age of 45 and its incidence is highest among those 
over the age of 55 (ACS 2009a).  In CT 6501.01, seven of the eight (88%) individuals diagnosed 
with kidney/renal pelvis cancer between 1996 and 2000 were over the age of 55, with an average 
age of 71 years at diagnosis.   
 
Some lifestyle-related factors have been identified as risk factors for the development of 
kidney/renal pelvis cancer.  They include smoking and obesity (ACS 2009a).  Of the eight 
individuals diagnosed with kidney/renal pelvis cancer in CT 6501.01 between 1996 and 2000, 
two reported being current or former smokers at the time of diagnosis.  No information on 
history of tobacco use was reported to the MCR for three individuals.  Information on some risk 
factors such as obesity is not reported to the MCR.   
 
Occupational exposure to certain substances such as asbestos, cadmium, benzene, organic 
solvents and some herbicides may also increase the risk of developing kidney/renal pelvis cancer 
(ACS 2009a).  Occupational information as reported to the MCR at the time of diagnosis was 
reviewed for the eight individuals diagnosed with kidney/renal pelvis cancer in CT 6501.01 
during 1996-2000 to determine the role that workplace factors may have played in the 
development of these cancers.  It should be noted, however, that occupational data reported to 
the MCR are generally limited to job title and often do not include specific job duty information 
that could further define exposure potential for individual diagnoses.  In addition, these data are 
often incomplete as occupational information can be reported as unknown, at home, or retired.  
In CT 6501.01, three of the eight individuals diagnosed with kidney/renal pelvis cancer during 
1996-2000 reported working in jobs possibly associated with an increased risk of kidney/renal 
pelvis cancer.  Occupation was reported as unknown or at home for three individuals.     
 
The histologies or subtypes of kidney/renal pelvis cancer in the eight individuals were also 
reviewed and compared to what would be expected, based on the medical literature and national 
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 cancer statistics.  In general, about 90% of all diagnoses of kidney/renal pelvis cancer are renal 
cell carcinomas (ACS 2009a).  In CT 6501.01, four individuals were diagnosed with renal cell 
carcinomas.  Histological information as reported to the MCR at the time of diagnosis was not 
specified for three of the other individuals.   
 
The geographic and temporal distribution of the reported residences of individuals in CT 6501.01 
diagnosed with kidney/renal pelvis cancer during 1996-2000 was reviewed.  Although some 
diagnoses occurred among individuals whose residences at the time of diagnosis were in relative 
close proximity to one another, the geographic distribution generally followed the population 
density of the CT.  From a temporal (i.e., time of diagnosis) perspective, all eight diagnoses 
occurred within a two year period.  A review of the geographic distribution of individuals 
diagnosed with kidney/renal pelvis cancer between 2001 and 2005 also generally followed the 
population density of the CT.  No temporal clustering occurred during this later time period as 
the dates of diagnosis were spread fairly evenly across the 5-year period.   
2. Liver/Intrahepatic Bile Duct Cancer Incidence 
Although the differences between the number of observed diagnoses and expected diagnoses of 
liver/intrahepatic bile duct cancer in CT 6501.01 during 1996-2000 and 2001-2005 were only 
one or two diagnoses, it was evaluated further because this is a fairly rare cancer type in the 
United States.  Among males, the incidence in CT 6501.01 was slightly elevated during 1996-
2000 (2 diagnoses observed compared to 1 expected) and 2001-2005 (3 diagnoses observed 
compared to about 1 expected).  Neither difference was statistically significant.  Among females, 
the incidence of liver/intrahepatic bile duct cancer was as expected during both time periods.  
 
Available risk factor information was reviewed for the seven individuals in CT 6501.01 
diagnosed with liver/intrahepatic bile duct cancer between 1996 and 2005.  According to the 
ACS, more than 90% of individuals diagnosed with liver/intrahepatic bile duct cancer are older 
than 45 years of age, with an average age at diagnosis of 63 years (ACS 2012).  In CT 6501.01, 
all 7 individuals diagnosed with liver/intrahepatic bile duct cancer between 1996 and 2005 were 
over the age of 45, with an average age of 66 years at diagnosis.   
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 Some hereditary and medical conditions have been identified as risk factors for the development 
of liver/intrahepatic bile duct cancer.  They include chronic infection with the hepatitis B virus or 
hepatitis C virus, cirrhosis (a disease in which liver cells become damaged and are replaced by 
scar tissue), and certain inherited metabolic diseases that can lead to cirrhosis (ACS 2012).  
Information on these risk factors is not reported to the MCR.   
 
Exposure to vinyl chloride, a chemical used in making some kinds of plastics, may raise the risk 
of developing liver/intrahepatic bile duct cancer.  Exposure of workers to vinyl chloride is now 
strictly regulated in the United States.  In CT 6501.01, no individuals diagnosed with 
liver/intrahepatic bile duct cancer during 1996-2005 reported working in a job possibly 
associated with an increased risk liver/intrahepatic bile duct cancer.  Occupation was reported as 
unknown for one individual.   
 
The histologies of liver/intrahepatic bile duct cancer in the seven individuals were also reviewed 
and compared to what would be expected based on the medical literature and national cancer 
statistics.  According to the ACS, hepatocellular carcinoma is the most common type of liver 
cancer in adults and accounts for about 75% of all diagnoses (ACS 2012).  In CT 6501.01, six 
individuals were diagnosed with hepatocellular carcinoma.  Histological information as reported 
to the MCR at the time of diagnosis was not specified for one individual.   
 
 The geographic distribution of place of residence for individuals in CT 6501.01 diagnosed with 
liver/intrahepatic bile duct cancer during 1996-2005 was reviewed.  Although some diagnoses 
occurred among individuals whose residences at the time of diagnosis were in relative close 
proximity to one another, these occurrences were located in areas of higher population density.  
From a temporal perspective, the dates of diagnosis for all seven individuals were spread fairly 
evenly over a six-year period.   
3. Lung and Bronchus Cancer Incidence 
The incidence of lung and bronchus cancer in males and females combined was about as 
expected in CT 6501.01 during both time periods evaluated.  A separate evaluation by gender 
showed that among females, the incidence of lung and bronchus cancer was either less than or 
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 about as expected during both time periods.  Among males, the incidence of lung and bronchus 
cancer was elevated during 1996-2000 (19 diagnoses observed compared to about 13 expected), 
though this difference was not statistically significant.  During 2001-2005, the incidence of lung 
and bronchus cancer among males was about as expected.   
 
Available risk factor information was reviewed for males in CT 6501.01 diagnosed with lung 
and bronchus cancer between 1996 and 2000.  According to the ACS, lung and bronchus cancer 
mainly occurs in older individuals, with roughly two-thirds of those diagnosed older than 65 
years of age.  In CT 6501.01, 12 of the 19 (63%) males diagnosed with lung and bronchus cancer 
during this time period were 65 years of age or older at the time of diagnosis.  The average age at 
diagnosis was 67 years, which is consistent with the national average of 71 years and the state 
average of 69 years.   
 
The histologies of lung and bronchus cancer in the 19 males were reviewed and compared to 
what would be expected, based on the medical literature and national cancer statistics.  
According to the ACS, about 85% to 90% of all diagnoses of lung and bronchus cancers are non-
small cell lung cancer (NSCLC), with small-cell lung cancer (SCLC) comprising the remaining 
10% to 15% (ACS 2008a).  In CT 6501.01, nine males were diagnosed with NSCLC and six 
were diagnosed with SCLC.  Histological information as reported to the MCR at the time of 
diagnosis was not specified for four individuals.   
 
Tobacco use is by far the most important risk factor for lung and bronchus cancer.  It is estimated 
that 85% to 95% of deaths from lung and bronchus cancer are caused by smoking.  The longer a 
person has been smoking and the higher the number of cigarettes smoked per day, the greater the 
risk of lung and bronchus cancer.  No matter the age of an individual or how long someone has 
used tobacco, quitting may help an individual to live longer.  It should be noted that SCLC is 
almost always caused by smoking and rarely develops in an individual who has never smoked 
(ACS 2008a,b).  For the 10 males diagnosed with lung and bronchus cancer in CT 6501.01 
during 1996-2000 with a known tobacco history, eight (80%) were current or former tobacco 
users.  The tobacco history of nine of the 19 males is unknown.  Of the six males diagnosed with 
SCLC, three were current or former smokers and the tobacco history of the remaining three 
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 individuals is unknown.  On a statewide level, about 93% of individuals in Massachusetts that 
were diagnosed with lung and bronchus cancer during 1996-2000 and had a known tobacco 
history were current or former tobacco users.   
 
Exposures to several substances, particularly radon, have been identified as important risk factors 
in the development of lung and bronchus cancer.  Radon is a naturally occurring radioactive gas 
produced by the breakdown of uranium in soils and rocks.  High indoor levels of radon can occur 
in homes and buildings, especially in basements.  Exposure to radon has been identified as the 
second leading cause of lung and bronchus cancer, and the leading cause among nonsmokers.  
According to the USEPA, homes within Bristol County have moderate potential for elevated 
radon levels (USEPA 2009).  However, radon levels cannot be more accurately predicted based 
on state, local, and neighborhood radon measurements because of natural geologic variability.  
Even homes which are next to each other can have different radon levels.  Testing of individual 
homes is the only way to find out the radon level in a home.   
 
Workplace exposure to asbestos has also been identified as an established risk factor for lung and 
bronchus cancer.  Exposure to asbestos may occur in mines, mills, textile plants, shipyards, and 
where insulation is used.  Asbestos is not usually considered harmful as long as it is not released 
into the air by deterioration, demolition, or renovation.  Additional chemical compounds that are 
occupational risk factors include arsenic, beryllium, cadmium, silica, vinyl chloride, nickel 
compounds, chromium, coal products, mustard gas, chloromethyl ethers, diesel exhaust, and 
radioactive ores such as uranium (ACS 2008a,b).  The risk of developing lung and bronchus 
cancer from workplace exposure to these chemicals is even higher for smokers.  Occupational 
information as reported to the MCR at the time of diagnosis was reviewed for the 19 males 
diagnosed with lung and bronchus cancer in CT 6501.01 during 1996-2000 to determine the role 
that workplace factors may have played in the development of these cancers.  As mentioned 
previously, occupational data reported to the MCR are generally limited to job title and often do 
not include specific job duty information that could further define exposure potential for 
individual diagnoses.  In addition, these data are often limited as occupational information can be 
reported as unknown, at home, or retired.  In CT 6501.01, six of the 19 individuals diagnosed 
with lung and bronchus cancer during 1996-2000 reported working in jobs possibly associated 
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 with an increased risk of lung and bronchus cancer.  Occupation was reported as unknown or 
retired for two individuals.   
 
The geographic and temporal distribution of place of residence for individuals in CT 6501.01 
diagnosed with lung and bronchus cancer between 1996 and 2000 was reviewed.  In general, the 
spatial distribution of diagnoses followed the population density of the CT.  Although some 
diagnoses occurred among individuals whose residences at the time of diagnosis were in relative 
close proximity to one another, these occurrences were located in areas of higher population 
density.  In addition, there was no temporal clustering as the dates of diagnosis were spread fairly 
evenly across the 5-year period.  Furthermore, a review of the geographic distribution of 
individuals diagnosed with lung and bronchus cancer between 2001 and 2005 similarly followed 
the population density of the CT.   
4. Prostate Cancer Incidence 
The incidence of prostate cancer in CT 6501.01 was less than expected during 1996-2000 (22 
diagnoses observed compared to 26 expected) but greater than expected during 2001-2005 (31 
diagnoses observed compared to approximately 25 expected) based on the statewide cancer 
experience.  However, this elevation was not statistically significant.   
 
Available risk factor information was reviewed for those men in CT 6501.01 diagnosed with 
prostate cancer between 2001 and 2005.  According to the ACS, age is the strongest risk factor 
for prostate cancer.  Prostate cancer is very rare before the age of 40, but the risk of developing it 
rises rapidly after age 50.  Almost 2 out of 3 men diagnosed with prostate cancer are over the age 
of 65 at diagnosis (ACS 2009b).  In CT 6501.01, 16 of the 31 (52%) men diagnosed with 
prostate cancer between 2001 and 2005 were over the age of 65, with an average age at diagnosis 
of 67 years.   
 
The histologies of prostate cancer in the 31 individuals were also reviewed and compared to 
what would be expected, based on the medical literature and national cancer statistics.  
According to the ACS, over 99% of prostate cancers are adenocarcinomas (ACS 2009b).  In CT 
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 6501.01, 30 men were diagnosed with adenocarcinomas.  Histological information as reported to 
the MCR at the time of diagnosis was not specified for one individual.   
 
The geographic and temporal distribution of place of residence for males in CT 6501.01 
diagnosed with prostate cancer between 2001 and 2005 was reviewed.  The spatial distribution 
generally followed the population distribution of the CT.  Although some diagnoses occurred 
among individuals whose residences at the time of diagnosis were in relative close proximity to 
one another, these occurrences were located in areas of higher population density.  In addition, 
there was no temporal clustering as the dates of diagnosis of the 31 individuals were spread fairly 
evenly across the 5-year period.   
B. Cancer Incidence in CT 6501.02 
In general, cancer incidence in CT 6501.02 was approximately at or near that which was 
expected during both time periods evaluated (see Tables 7 and 8).  In each of the two time 
periods, the incidence of the following three cancer types in both genders was either less than 
expected or about as expected when compared to the statewide cancer experience: bladder, 
breast, and lung and bronchus.  For these three cancer types, if the number of observed diagnoses 
was greater than the number expected, the difference was based on one or two diagnoses and was 
not statistically significant.  The geographic and temporal distribution of diagnoses for each of 
these three cancer types was also reviewed.  Although diagnoses did occur among individuals 
whose residences at the time of diagnosis were located within Pine Hill Acres and near the New 
Bedford Business Park, the spatial distribution for each cancer type generally followed the 
population density pattern within the CT.  In addition, the temporal distribution of diagnoses was 
not unusual.  The incidence rate of the remaining three cancer types – kidney/renal pelvis, 
liver/intrahepatic bile duct and prostate cancer – showed slightly greater variability.  However, 
no elevations in the incidence of these cancer types were statistically significant, indicating that 
they could represent natural or random variation.  The incidence of kidney/renal pelvis cancer, 
liver/intrahepatic bile duct cancer and prostate cancer in CT 6501.02 are discussed further below.   
1. Kidney/Renal Pelvis 
Although the incidence of kidney/renal pelvis cancer in males and females combined was about 
as expected in CT 6501.02 during both time periods evaluated, a separate evaluation by gender 
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 revealed a slightly different pattern.  Among females, the incidence of kidney/renal pelvis cancer 
was either less than or about as expected during both time periods.  Among males, however, the 
incidence of kidney/renal pelvis cancer was slightly elevated during 1996-2000 (4 diagnoses 
observed compared to approximately 2 expected), though this difference was not statistically 
significant.  During 2001-2005, the incidence of kidney/renal pelvis cancer among males was 
about as expected.   
 
Available risk factor information was reviewed for those individuals in CT 6501.02 diagnosed 
with kidney/renal pelvis cancer between 1996 and 2000.  As mentioned previously, the incidence 
of kidney/renal pelvis cancer is highest among those over the age of 55 and the average age of 
individuals diagnosed with this cancer type is 65 years (ACS 2009a).  In CT 6501.02, two of the 
four (50%) individuals diagnosed with kidney/renal pelvis cancer between 1996 and 2000 were 
over the age of 65.  The average age at diagnosis for all four individuals was 56 years.  Although 
smoking is an established risk factor for kidney/renal pelvis cancer, history of tobacco use was 
unknown for three of the four individuals diagnosed in this CT during 1996-2000.  Occupational 
information as reported to the MCR at the time of diagnosis was reported as unknown for one of 
the four individuals.  Of the remaining three individuals diagnosed with kidney/renal pelvis 
cancer during 1996-2000, one reported working in a job possibly associated with an increased 
risk of kidney/renal pelvis cancer.   
 
The histologies of kidney/renal pelvis cancer in the four individuals were also reviewed and 
compared to what would be expected, based on the medical literature and national cancer 
statistics.  In CT 6501.02, three individuals (75%) were diagnosed with renal cell carcinomas.  
This is consistent with the national trend in which about 90% of all diagnoses of kidney/renal 
pelvis cancer are renal cell carcinomas (ACS 2009a).  Histological information as reported to the 
MCR at the time of diagnosis was not specified for one individual.    
 
The geographic and temporal distribution of the reported residences of individuals in CT 6501.02 
diagnosed with kidney/renal pelvis cancer during 1996-2000 was reviewed.  The spatial 
distribution of diagnoses generally followed the population density pattern of the CT.  Although 
two diagnoses occurred among individuals whose residences at the time of diagnosis were in 
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 relative close proximity to one another, this occurrence was located in an area of higher 
population density.  From a temporal perspective, two diagnoses occurred within a period of one 
month.  The four diagnoses occurred over a four year period.  However, it is difficult to ascertain 
the significance of this, if any, due to the latency period for kidney/renal pelvis cancer and the 
small number of individuals diagnosed with this type of cancer.  A review of the geographic 
distribution of individuals diagnosed with kidney/renal pelvis cancer during 2001 and 2005 
similarly did not show any unusual spatial patterns.   
2. Liver/Intrahepatic Bile Duct Cancer Incidence 
As mentioned previously, liver/intrahepatic bile duct cancer is fairly rare in the United States.  
For this reason, the incidence of this cancer type was further evaluated.  In CT 6501.02, no 
diagnoses of liver/intrahepatic bile duct cancer were observed during 1996-2000.  During 2001-
2005, two diagnoses were observed compared to about one expected.  The incidence of 
liver/intrahepatic bile duct cancer among males was about as expected (1 observed diagnosis 
compared to about 1 expected) whereas that among females was slightly elevated (1 observed 
diagnosis compared to 0 expected).  These differences were not statistically significant.   
 
Available risk factor information was reviewed for those individuals diagnosed in CT 6501.02 
with liver/intrahepatic bile duct cancer between 2001 and 2005.  As discussed previously, more 
than 90% of individuals diagnosed with liver/intrahepatic bile duct cancer in the United States 
are older than 45 years of age, with an average age at diagnosis of 63 years (ACS 2012).  In CT 
6501.02, both individuals diagnosed with liver/intrahepatic bile duct cancer during 2001-2005 
were over the age of 45, with an average age of 57 years.   
 
Although some hereditary and medical conditions (e.g., chronic infection with the hepatitis B 
virus or hepatitis C virus, cirrhosis) have been identified as risk factors for the development of 
liver/intrahepatic bile duct cancer, this information is not reported to the MCR.  Furthermore, 
neither of the two individuals in CT 6501.02 diagnosed with liver/intrahepatic bile duct cancer 
during 2001-2005 reported working in a job possibly associated with an increased risk of 
liver/intrahepatic bile duct cancer.   
 
45 
 The histologies of liver/intrahepatic bile duct cancer in the two individuals diagnosed in CT 
6501.02 during 2001-2005 were hepatocellular carcinomas.  This is consistent with the national 
trend in which about 75% of all diagnoses of liver/intrahepatic bile duct cancer are hepatocellular 
carcinomas (ACS 2012).   
 
Although one diagnosis was located near the New Bedford Business Park, it was within an area 
of higher population density within the CT.  In general, no unusual geographic or temporal 
patterns were observed.   
3. Prostate Cancer Incidence 
In CT 6501.02, the incidence of prostate cancer was less than expected during 1996-2000 (13 
diagnoses observed compared to about 16 expected) but slightly greater than expected during 
2001-2005 (19 diagnoses observed compared to about 16 expected) based on the statewide 
cancer experience.  It is important to note, however, that while the number of observed diagnoses 
was greater than the number of expected diagnoses, the difference was not statistically 
significant.   
 
Available risk factor information was reviewed for those men in CT 6501.02 diagnosed with 
prostate cancer between 2001 and 2005.  As mentioned previously, age is the strongest risk 
factor for prostate cancer with almost 2 out of 3 diagnoses occurring in men over the age of 65 
(ACS 2009b).  In CT 6501.02, 9 of the 19 (47%) men diagnosed with prostate cancer between 
2001 and 2005 were over the age of 65, with an average age at diagnosis of 67 years.  
 
The histologies of prostate cancer in the 19 individuals were also reviewed and compared to 
what would be expected, based on the medical literature and national cancer statistics.  All 19 
(100%) of the men in CT 6501.02 were diagnosed with adenocarcinomas, which is consistent 
with the national trend in which over 99% of prostate cancers are adenocarcinomas.   
 
The geographic and temporal distribution of place of residence for males in CT 6501.02 
diagnosed with prostate cancer between 2001 and 2005 was reviewed.  The spatial distribution of 
diagnoses generally followed the population density of the CT.  Although many diagnoses 
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 occurred among individuals whose residences at the time of diagnosis were located within Pine 
Hill Acres, this is an area with relatively high population density.  In addition, there was no 
temporal clustering as the dates of diagnosis of the 19 individuals were spread fairly evenly 
across the 5-year period.   
VII. Discussion 
MDPH/BEH reviewed available environmental data related to specific facilities within the New 
Bedford Business Park to assess possible exposure opportunities to constituents related to these 
properties.  In addition, asthma hospitalization and cancer incidence data were reviewed to help 
address community concerns about possible impacts of these facilities on the pattern of disease 
in nearby neighborhoods. 
 
The New Bedford Business Park was initially developed in 1960 and currently consists of more 
than 40 businesses.  In the past, a number of properties within the business park have had a 
release of oil or other hazardous material that was reported to MDEP under the statewide 
hazardous waste site cleanup program.  Most of these releases were localized, addressed with an 
immediate response action, and considered by MDEP to pose no significant risk of health or 
environmental impacts.  This health consultation focused on facilities within the business park 
that had a release of oil or hazardous material that was under regulation or remediation at the 
time that this investigation was initiated, as well as the former Polaroid facility, which was of 
particular community concern.   
 
All of the sites within the New Bedford Business Park in this investigation (former BorgWarner, 
Polymerine, Tallyrand and Polaroid) had releases to the environment that resulted in 
groundwater contamination.  Importantly, all residential areas near the business park are either 
served by municipal drinking water supplies and, hence, do not use local groundwater for 
household water, or are located upgradient from the business park.  In addition, nearby residents 
would not be affected by groundwater contamination through possible vapor intrusion into 
houses due to the distance to the nearest residences.  Thus, we would not expect adverse health 
impacts associated with groundwater contamination in the past, present, or future. 
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 Three sites (the former BorgWarner, Polymerine, and Tallyrand facilities) all had soil 
contamination that included PCBs and/or petroleum compounds.  In all cases, extensive soil 
removal was conducted.  Remediation efforts are ongoing at the former BorgWarner and 
Polymerine sites.  Although it was possible for an individual to contact soils containing some of 
these compounds in the past, it is unlikely that anyone came into contact with contaminated soils 
on a regular basis currently or in the past given the nature of the site as an industrial business 
park.  However, even under the highly unlikely possibility that an individual frequently visited 
and/or played at the former Polymerine or Tallyrand sites in the past or currently, health impacts 
would not be expected from contact with contaminated soils.  The business park is expected to 
continue as such for the foreseeable future, and hence, health impacts are not expected under 
future scenarios. 
 
The former Polaroid facility is not under active investigation or remediation.  However, nearby 
residents had specific concerns about historical exposure opportunities from this facility, 
particularly from air emissions.  Based on available data, this facility emitted methanol, MEK 
and hydrochloric acid in the past and was generally in compliance with air quality permit 
specifications with the exception of two violations, after which corrective actions were promptly 
taken.  Although these compounds can produce noticeable odors and may cause a range of health 
concerns such as headaches and respiratory irritation from long term exposure, they have not 
been classified with respect to carcinogenicity.  No ambient air quality concentration data were 
available for this facility, from either onsite or offsite locations.  Thus, it is difficult to 
quantitatively evaluate exposure opportunities that may have occurred in the past.  However, 
since MEK is a respiratory irritant, the MDPH examined available hospital discharge data for 
asthma hospitalizations of residents of zip code 02745 during 2000-2003.  This four-year time 
period reflects the most complete data available through 2003, after which point MEK was no 
longer emitted from the former Polaroid facility.   
 
The number of asthma hospitalizations in zip code 02745 generally increased during 2000-2003.  
The total number of hospitalizations during this four-year time period was greater than expected 
based on the statewide experience and the difference was of borderline statistical significance.  
The number of asthma hospitalizations in zip code 02745 was statistically significantly lower 
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 than expected in 2000 whereas the number was statistically significantly elevated in 2003.  
Overall, there does not appear to be a relationship between the level of emissions of MEK from 
the former Polaroid facility and the number of asthma hospitalizations within zip code 02745 
during 2000-2003.  The level of emissions of MEK generally decreased over this time period and 
a corresponding decrease in the number of asthma hospitalizations was not observed.   
 
To address community concerns about cancer incidence, the CAP reviewed cancer incidence 
data available from the MCR for six cancer types (bladder, breast, kidney/renal pelvis, 
liver/intrahepatic bile duct, lung and bronchus, and prostate cancer) in the two CTs (6501.01 and 
6501.02) containing the neighborhoods of concern during the 10-year time period, 1996-2005.  
The six cancer types evaluated were chosen based on residents’ concerns over suspected 
elevations of these cancer types.   
 
According to ACS statistics, cancer is the second leading cause of death in Massachusetts and 
the United States.  Not only will one out of three women and one out of two men develop cancer 
in their lifetime, but cancer will affect three out of every four families.  For this reason, cancers 
often appear to occur in “clusters,” and it is understandable that someone may perceive that there 
are an unusually high number of cancer cases in their neighborhood or town.  Upon close 
examination, many of these “clusters” are not unusual increases, as first thought, but are related 
to such factors as local population density, variations in reporting or chance fluctuations in 
occurrence.  In other instances, the “cluster” in question includes a high concentration of 
individuals who possess related behaviors or risk factors for cancer.  Some, however, are 
unusual; that is, they represent a true excess of cancer in a workplace, a community, or among a 
subgroup of people.  A suspected cluster is more likely to be a true cancer cluster if it involves a 
large number of cases of one type of cancer diagnosed in a relatively short time period rather 
than several different types diagnosed over a long period of time (i.e., 20 years), a rare type of 
cancer rather than common types, and/or a large number of cases diagnosed among individuals 
in age groups not usually affected by that cancer.  These types of clusters may warrant further 
public health investigation.   
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 In general, there does not seem to be an unusual pattern of cancer incidence in either CT 6501.01 
or 6501.02.  In both CTs, the incidence of bladder and breast cancer was either less than or about 
as expected based on the statewide cancer experience during 1996-2000 and 2001-2005.  For 
these two cancer types, if the number of observed diagnoses was greater than the number 
expected, the difference was based on one or two diagnoses and was not statistically significant.  
Although there were elevations in cancer of the kidney/renal pelvis, liver/intrahepatic bile duct, 
lung and bronchus, and prostate during certain time periods, in no case was the difference 
between the numbers of observed and expected diagnoses statistically significant, meaning that 
they could be due to chance and represent natural variability in rates.   
 
Available risk factor information on tobacco use and occupation for those diagnosed with 
kidney/renal pelvis in both CTs and those diagnosed with lung and bronchus cancer in CT 
6501.01 were compared to known or established trends to assess whether any unexpected 
patterns occurred.  Review of these data suggests that tobacco use likely played some role in the 
development of these cancers among some individuals.  Occupational exposures may have also 
been important in the development of these cancers among some individuals.  However, because 
of the large number of individuals for whom tobacco history and/or occupation was unknown, it 
is difficult to fully assess the extent to which these factors influenced the overall cancer pattern.   
 
Because liver/intrahepatic bile duct cancer is a fairly rare cancer type in the United States, 
available risk factor information on age and occupation was reviewed for those individuals 
diagnosed in CT 6501.01 and 6501.02 during 1996-2005.  The ages at diagnosis for these 
individuals were consistent with national statistics.  In addition, the available data suggest that 
occupational exposures are unlikely to have played a role in the development of these cancers 
amongst these individuals.  According to the ACS, the incidence of liver/intrahepatic bile duct 
cancer in the United States has been rising slowly for several decades.   
 
Available risk factor information was also reviewed for those men diagnosed with prostate 
cancer in both CTs, with an emphasis on age as this is the strongest risk factor for this cancer 
type.  It should be noted that prostate cancer is the most common cancer (other than skin cancers) 
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 in American men.  The ACS estimates that about 1 man in 6 will be diagnosed with prostate 
cancer during his lifetime.   
 
The analysis of the geographic distribution of address at the time of diagnosis for individuals 
diagnosed with the six cancer types evaluated in the two CTs did not reveal any atypical spatial 
patterns that would suggest a common factor (environmental or non-environmental) played a 
primary role in the incidence of cancer in either CT during the 10-year time period, 1996-2005.  
Although diagnoses did occur among individuals whose residences at the time of diagnosis were 
located within the two neighborhoods of interest, the spatial distribution for each cancer type 
generally followed the population density pattern within the CT.   
VIII. Limitations 
This health consultation is an investigation that analyzed descriptive health outcome data for 
asthma hospitalizations and cancer incidence to determine whether the pattern or occurrence of 
disease in CTs 6501.01 and 6501.02 is unusual.  The purpose of this investigation was to 
evaluate the pattern of cancer in a geographical context in relation to available information about 
risk factors, including environmental factors, related to six specific cancer types to determine 
whether further investigation seems warranted.  Information from descriptive analyses, which 
may suggest a common etiology (or cause) is possible, can serve to identify areas where further 
analyses may be needed.  However, inherent limitations in the available data make it impossible 
to determine the precise causal relationships or synergistic roles that may have contributed to the 
development of individual cancers in this community.  Also, this type of analysis cannot 
determine what may have caused cancer in any one particular individual.  Cancers in general 
have a variety of risk factors known or suggested to be related to the cause of the disease that 
could not be evaluated in this investigation.  It is believed that many cancers are related largely 
to lifestyle factors such as tobacco use, diet, and alcohol consumption.  Other factors associated 
with cancer include socioeconomic status, heredity/genetics, race, and geography.  It is beyond 
the scope of this investigation to determine the causal relationship of these factors and the 
development of cancer in these two CTs.   
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 IX. Conclusions  
Based on the MDPH’s evaluation of the available environmental data, the exposure pathway 
analysis, asthma hospitalization data, and risk factor information related to the six cancer types 
evaluated (bladder, breast, kidney/renal pelvis, liver/intrahepatic bile duct, lung and bronchus, 
and prostate cancer), MDPH concludes that:  
 Drinking tap water in the past, present or future is not expected to harm people’s 
health.  The reason for this is because groundwater at the former BorgWarner, 
Polymerine, Tallyrand, and Polaroid sites was not used for drinking water historically and 
is not used as a source presently.  The surrounding neighborhoods are generally served by 
the City of New Bedford Water Department, with the exception of possible private wells 
on Braley Road that are located upgradient.  As a result, there are no completed 
groundwater exposure pathways in the past, present, or future.  In addition, there are no 
completed vapor intrusion exposure pathways resulting from releases at these four sites 
for nearby residents in the past, present or future.   
 Incidentally eating or touching soil or sediment while at the former Polymerine or 
Tallyrand sites in the past is not expected to have harmed people’s health.  The reason 
for this is because, based on the available information and conservative assumptions 
about the frequency and duration of potential past exposures of trespassers, levels of 
chemical contaminants that could get into an adult or older child’s body are below levels 
that would harm their health.   
 Incidentally eating or touching soil or sediment at the former Polymerine or 
Tallyrand sites presently or in the future is not expected to harm people’s health.  
Although removal activities were conducted at the former Polymerine site, PCBs were 
still detected in remaining on-site surface soils at levels above health-based comparison 
values.  Likewise, although remediation at the former Tallyrand site included the removal 
of contaminated soil, PCBs remaining in on-site surface soil are not expected at 
concentrations above the USEPA action level but could still exceed health-based 
comparison values.  However, based on conservative assumptions about the frequency 
and duration of potential exposures in the present or future, levels of chemical 
contaminants that could get into an adult or older child’s body while trespassing at either 
the former Polymerine or Tallyrand sites are below levels that would harm their health.   
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  Incidentally eating or touching soil at the former Polaroid facility in the past, 
present or future is not expected to harm people’s health.  The reason for this is because 
no exposures to contaminated soil from the release of sulfuric acid at the former Polaroid 
facility are expected to occur due to the depth below ground surface.   
 Exposure of nearby residents to chemicals in air emissions from the former Polaroid 
facility was possible when the facility was in operation.  Since there are no historical 
ambient air data available for the facility or the surrounding neighborhoods, it is not 
possible to quantitatively evaluate whether facility emissions may have resulted in 
chemical concentrations in ambient air greater than health-based comparison values.  
Since MEK is a respiratory irritant, the MDPH examined available hospital discharge 
data for asthma hospitalizations of residents of zip code 02745 during the four-year time 
period of 2000-2003.  Overall, there does not appear to be a relationship between the 
level of emissions of MEK from the former Polaroid facility and the number of asthma 
hospitalizations within the zip code.  The use of MEK at the former facility was 
discontinued after 2003. 
 Within CT 6501.01, the incidence of bladder and breast cancer in both genders 
during 1996-2000 and 2001-2005 was either less than or about as expected based on the 
statewide cancer experience.   
 Within CT 6501.01, the incidence of kidney/renal pelvis, lung and bronchus, and 
prostate cancer was elevated during one of the two time periods evaluated and varied by 
gender.  However, no elevations were statistically significant.   
 Within CT 6501.02, the incidence of bladder, breast, and lung and bronchus cancer 
was either less than or about as expected among males and females during 1996-2000 and 
2001-2005.   
 Within CT 6501.02, the incidence of kidney/renal pelvis and prostate cancer was 
either elevated or slightly elevated among males during one of the two time periods 
evaluated.  No elevations, however, were statistically significant.   
 Within CT 6501.01 and CT 6501.02, the incidence of liver/intrahepatic bile duct 
cancer, which is fairly rare in the United States, was slightly greater than expected and 
varied by gender.  However, no elevations were statistically significant.       
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  Review of risk factor information suggests that tobacco use likely played some role in 
the development of kidney/renal pelvis and lung and bronchus cancer among some 
individuals.  Occupational exposures may have also been important in the development 
of these cancer types among some individuals.  It is difficult to fully assess the extent to 
which these factors influenced overall cancer patterns due to the number of individuals 
for whom tobacco history and/or occupation was unknown.   
 Analysis of the geographic distribution of place of residence for individuals diagnosed 
with the six cancer types evaluated in the two CTs revealed spatial patterns that generally 
followed the population density pattern.  Although several diagnoses did occur among 
individuals whose residences at the time of diagnosis were located within the two 
neighborhoods of interest, these were areas of relative higher population density.   
X. Recommendations 
The MDPH recommends no further investigation of cancer incidence in CTs 6501.01 and 
6501.02 at this time.   
 
For more information about quitting smoking, contact the Massachusetts Tobacco Cessation and 
Prevention Program at 1-800-Quit-Now or 1-800-784-8669 or visit the website 
http://makesmokinghistory.org/.   
 
The only way to know if your home has a radon problem is to do a radon test.  The MDPH 
recommends that all residences in Massachusetts be tested for radon.  For further questions about 
radon, you may contact the MDPH/BEH’s Radiation Control Program at 1-800-723-6695 for 
advice on home testing.   
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Figure 1 
Location of Environmental Concern 
New Bedford, Massachusetts
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Figure 2 
Area of Analysis 
New Bedford, Massachusetts 
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Figure 3 
Surface Soil Samples Prior to 1998 Excavation at the Former Polymerine Site 
New Bedford, Massachusetts 
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Figure 4 
Surface Soil Samples Prior to 2000-2001 Excavation at the Former Polymerine Site 
New Bedford, Massachusetts 
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Figure 5 
Post-Excavation Soil Surface Samples Collected in 2008-2009 at the Former Polymerine Site 
New Bedford, Massachusetts 
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Figure 6 
Former Tallyrand Site Map and Release Area 
New Bedford, Massachusetts 
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Figure 7 
Area of Analysis for Asthma Hospitalization Data 
Zip Code 02745, New Bedford, Massachusetts 
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 Table 1 
Maximum Concentrations of Contaminants Detected in On-Site Sediment and Soil Samples  
at the Former Polymerine Site that Exceed Comparison Values  
 
Intermediate EMEG (child) = 500
Intermediate EMEG (adult) = 7,000
CREG = 0.4
MDEP S-1 & GW-1 standard = 2
CREG2 = 0.4
MDEP S-1 & GW-1 standard = 2
Notes:
-- = No value available.  
1 Maximum concentration is the average of two duplicate samples (19,000 ppm, 15,000 ppm) taken at this location. 
2 Because ATSDR comparison values do not exist for sediment, soil comparison values were used for screening purposes.  
Data sources:   
Paragon. 1998. PCB Delineation Report. Former Polymerine, Inc. Site, 241 Duchaine Boulevard, New Bedford, Massachusetts. November 24. 
Roy F. Weston, Inc. 1998. Removal Program Preliminary Assessment/Site Investigation Report for the Polymerine Site, New Bedford, Massachusetts. January 7.
Roy F. Weston, Inc. 2001. Removal Program After Action Report for the Polymerine Site, New Bedford, Massachusetts. 12 April 2000 through 1 October 2001. November.
Intermediate EMEG (adult) = Environmental Media Evaluation Guide for adults (i.e., for exposures between 14 days and 1 year) (ATSDR, ATSDR 2008a)
MDEP S-1 & GW-1 = MCP Method 1 soil category S-1 standards applicable to soil where the combination of soil & groundwater categories are S-1 & GW-1 (MDEP, MDEP 2008)
CREG = Cancer Risk Evaluation Guide for 1 x 10-6 excess cancer risk (ATSDR, ATSDR 2008a)
Copper 10/6/1998 Unknown (surficial) 8,300Soil
1.2
Comparison values (source organization, reference):
Soil
Soil Background 
(ppm) Soil comparison value (ppm)
40 (natural soil)      
200 (fill material)
Intermediate EMEG (child) = Environmental Media Evaluation Guide for children (i.e., for exposures between 14 days and 1 year and considers vulnerabilities of children when it 
comes to environmental exposures) (ATSDR, ATSDR 2008a)
Total Polychlorinated 
Biphenyls 10/6/1998
West of the on-site buliding          
13S/30W (1-3 inches) 17,000 
1 --
Tighe & Bond. 2008. Phase I Initial Site Investigation, Tier Classification and Phase II Scope of Work, Former Polymerine, 241 Duchaine Boulevard, New Bedford, MA, DEP 
Contaminant Date of sample
Descriptive location of sample       
Sample depth (feet)
Maximum 
concentration 
(ppm)
Medium
Tighe & Bond. 2009. Phase II Comprehensive Site Assessment, Former Polymerine, 241 Duchaine Boulevard, New Bedford, MA, RTN 4-1347. May.
Total Polychlorinated 
Biphenyls Sediment 3/27/2009
Northwest of the on-site building      
Station C-42 (0 - 6 inches) --
Massachusetts Department of Environmental Protection, Office of Research and Standards. 2002. Technical Update: Background Levels of Polycyclic Aromatic Hydrocarbons and 
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 Table 2 
Maximum Concentrations of Contaminants Detected in On-Site Soil Samples  
at the Former Tallyrand Site that Exceed Comparison Values  
 
CREG = 0.4
MassDEP S-1 & GW-1 standard = 2
Total Petroleum Hydrocarbons 12/8/1995 Site SS2E (Surficial) 4,200 -- MassDEP S-1 & GW-1 standard = 1,000
Notes:
-- = No value available.  
Data sources:   
SITEC Environmental, Inc. 1996. Immediate Response Action Plan, RTN 4-11419. January 26.
Roy F. Weston, Inc. 1997. After Action Report for the New Bedford Industrial Park Removal Site, New Bedford, Massachusetts, 20 through 28 October 1997. December.
MassDEP S-1 & GW-1 = MCP Method 1 soil category S-1 standards applicable to soil where the combination of soil & groundwater categories are S-1 & GW-1 (MDEP, MDEP 
2008)
Soil 
Background 
(ppm)
Soil comparison value (ppm)Contaminant Date of 
sample
Descriptive location of sample       
Sample depth (feet)
Maximum 
concentration 
(ppm)
CREG = Cancer Risk Evaluation Guide for 1 x 10-6 excess cancer risk (ATSDR, ATSDR 2008a)
Comparison values (source organization, reference):
Total Polychlorinated Biphenyls 
(PCBs)
10/21/1997 1-FS-2.0-009 (2 feet) 13,500 --
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2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988
* WATER = Discharges to receiving streams or water bodies 
† NR = not reported 
‡ AIR STACK = Stack or point air emissions 
†† AIR FUG = Fugitive or non-point air emissions
‡‡ DISP NON METALS = Summation of a group of the methods that can be used to dispose of a metal or non-metal chemical off-site
§ 1995 and after "ACID AEROSOLS" only
Data source: Toxics Release Inventory (TRI) USEPA, 2008.
Chemical Name Media
Copper compounds WATER* NR† NR NR NR NR NR NR NR 0 0 NRNR 2 2 2 NR NR NR
Hydrochloric acid§ AIR STACK‡ NR NR NR NR
0
NR NR NR NR 1 1 1NR NR NR 1 1 1 0
Methanol AIR FUG†† 1500 4700 1800 1300
1
1900 400 700 600 100 100 100410 440 500 380 100 100 250
Methanol AIR STACK 12000 12000 18000 21000
132
15000 18000 29000 28000 33000 36000 3500028000 31200 32000 33000 44900 42700 42000
Methanol
DISP NON 
METALS‡‡
NR NR NR NR
39265
NR NR NR NR NR NR NRNR NR NR NR NR 110 NR
Methyl ethyl ketone AIR FUG NR NR NR 3900
NR
3200 5200 5500 5300 1500 NR NR5400 5500 6300 3700 NR NR NR
Methyl ethyl ketone AIR STACK NR NR NR 1400
3587
1000 2800 1700 2000 80 NR NR3100 3900 6600 5600 NR NR NR
Silver compounds DISP NON 
METALS
50 60 100 120
1450
NR NR120 NR80 120 120 120
Year (Pounds)
NR NRNR NR NR NRNR
Table 3 
Toxics Release Inventory Data for the Former Polaroid Facility (1988-2006) 
 
 Table 4 
Standard Hospitalization Ratio for Asthma 
Zip Code 02745, New Bedford, Massachusetts 
2000-2003 
Time Period Obs Exp SHR
2000 17 31.2 54 * 32  87
2001 39 32.0 122 87  166
2002 40 31.3 128 91  174
2003 58 38.7 150 * 114  194
2000 - 2003 154 133.4 115 98  135
Notes: Asthma is the primary cause of hospitalizaiton. 
SHRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SHR = Standardized Hospitalization Ratio * = Statistical significance
Data Source: MA Division of Health Care Finance and Policy (DHCFP). 
95% CI
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 Table 5 
Cancer Incidence, CT 6501.01 
New Bedford, Massachusetts 
1996-2000 
Cancer Type
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 6 6.1 98 36  -- 214 5 4.2 119 38  -- 278 1 1.9 NC NC  -- NC
Breast 19 27.5 69 42  -- 108 0 0.2 NC NC  -- NC 19 27.3 70 42  -- 109
Kidney and Renal Pelvis 8 4.1 197 85  -- 388 3 2.4 NC NC  -- NC 5 1.7 296 95  -- 691
Liver and Intrahepatic Bile Duct 3 1.6 NC NC  -- NC 2 1.0 NC NC  -- NC 1 0.5 NC NC  -- NC
Lung and Bronchus 27 25.3 107 70  -- 155 19 13.0 146 88  -- 229 8 12.3 65 28  -- 128
Prostate 22 26.1 84 53  -- 128 22 26.1 84 53  -- 128 0 NC NC NC  -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
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 Table 6 
Cancer Incidence, CT 6501.01 
New Bedford, Massachusetts 
2001-2005 
 
Cancer Type
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 6 4.7 128 47  -- 279 3 3.1 NC NC  -- NC 3 1.6 NC NC  -- NC
Breast 28 26.2 107 71  -- 155 0 0.2 NC NC  -- NC 28 26.0 108 72  -- 156
Kidney and Renal Pelvis 6 5.0 119 44  -- 260 4 2.9 NC NC  -- NC 2 2.1 NC NC  -- NC
Liver and Intrahepatic Bile Duct 4 2.0 NC NC  -- NC 3 1.4 NC NC  -- NC 1 0.6 NC NC  -- NC
Lung and Bronchus 29 26.5 109 73  -- 157 14 12.6 111 61  -- 187 15 13.9 108 60  -- 178
Prostate 31 24.9 125 85  -- 177 31 24.9 125 85  -- 177 0 NC NC NC  -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
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 Table 7 
Cancer Incidence, CT 6501.02 
New Bedford, Massachusetts 
1996-2000 
Cancer Type
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 4 3.2 NC NC  -- NC 2 2.4 NC NC  -- NC 2 0.8 NC NC  -- NC
Breast 14 16.0 88 48  -- 147 0 0.1 NC NC  -- NC 14 15.9 88 48  -- 148
Kidney and Renal Pelvis 4 2.5 NC NC  -- NC 4 1.5 NC NC  -- NC 0 0.9 NC NC  -- NC
Liver and Intrahepatic Bile Duct 0 0.9 NC NC  -- NC 0 0.7 NC NC  -- NC 0 0.2 NC NC  -- NC
Lung and Bronchus 12 14.1 85 44  -- 148 10 7.9 127 61  -- 234 2 6.3 NC NC  -- NC
Prostate 13 16.3 80 42  -- 136 13 16.3 80 42  -- 136 0 NC NC NC  -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
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Cancer Type
Obs Exp SIR Obs Exp SIR Obs Exp SIR
Bladder 2 2.4 NC NC  -- NC 1 1.7 NC NC  -- NC 1 0.7 NC NC  -- NC
Breast 15 15.9 94 53  -- 155 0 0.1 NC NC  -- NC 15 15.8 95 53  -- 156
Kidney and Renal Pelvis 4 3.1 NC NC  -- NC 2 1.9 NC NC  -- NC 2 1.2 NC NC  -- NC
Liver and Intrahepatic Bile Duct 2 1.2 NC NC  -- NC 1 0.9 NC NC  -- NC 1 0.3 NC NC  -- NC
Lung and Bronchus 14 14.9 94 51  -- 158 7 7.7 90 36  -- 186 7 7.1 98 39  -- 202
Prostate 19 16.3 116 70  -- 182 19 16.3 116 70  -- 182 0 NC NC NC  -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Bureau of Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
Total Males Females
95% CI 95% CI 95% CI
Table 8 
Cancer Incidence, CT 6501.02 
New Bedford, Massachusetts 
2001-2005 
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Exposure Dose and Cancer Risk Calculation Formulas: 
 
Noncancer Health Effects Exposure Factor: 
 days 365  ED
ED  F  NC_EF 
  
Noncancer Health Effects Exposure Dose (Ingestion): 
BW
CF  NC_EF  IR  [C]
  NC_D soil
  
Cancer Effects Exposure Factor: 
 days 365  years 70
ED  F  C_EF 
  
Cancer Effects Exposure Dose (Ingestion): 
BW
CF  C_EF  IR  [C]
  C_D soil
  
Cancer Risk: 
CSF  C_D  CR   
Where: 
   NC_EF  = Noncancer Exposure Factor (unitless) 
   F  = Frequency of Exposure (days/year) 
   ED  = Years of Exposure (years) 
   NC_D   = Noncancer Exposure Dose (mg/kg/day) 
   [C]soil   = Analyte Concentration in Soil (mg/kg) 
   IR   = Soil Ingestion Rate (mg/day) 
   CF   = Conversion Factor (kg/mg) 
   BW  = Body Weight (kg) 
   C_EF   = Cancer Exposure Factor (unitless) 
   C_D   = Cancer Exposure Dose (mg/kg/day) 
   CR   = Cancer Risk (unitless) 
   CSF   = Cancer Slope Factor (mg/kg/day –1) 
 Assumptions: 
1) The receptor evaluated was an older child who trespasses on the site. 
2) The soil concentration was assumed as either the maximum or average concentration of copper and 
PCBs detected in on-site surface soil. 
3) The amount of soil ingested was assumed to be 200 milligrams per day for the older child. 
4) The exposure factor was determined assuming the older child receptor was exposed to site soil 1 day 
per week, for 22 weeks per year (May through September) over a 5 year period.   
5) The average body weight of the older child receptor was assumed to be 45 kilograms. 
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1. Exposure Dose and Cancer Risk Calculations for Ingestion of On-Site Surface Soil Containing the 
Maximum Concentration of Copper by an Older Child Prior to Remediation: 
 
06.0
 days 365  years 5
years 5 r  weeks/yea22 day/week x 1 Factor  Exposure EffectsHealth Noncancer 
  
 
mg/kg/day 0.002  
kg 45
kg/mg10  0.06 mg/day  200  mg/kg 8,300  Dose Exposure EffectsHealth Noncancer 
-6   
 
 
NOTES: 
1. The ATSDR Intermediate MRL for copper is 0.01 mg/kg/day.  
2.  The EPA has not classified copper with respect to its cancer causing potential and has not developed an 
EPA Oral Cancer Slope Factor for copper.  Due to the lack of evidence for cancer health effects in 
humans, cancer risk was not calculated for copper. 
 
 
2. Exposure Dose and Cancer Risk Calculations for Ingestion of On-Site Surface Soil Containing the 
Average Concentration of PCBs by an Older Child Prior to Remediation: 
 
06.0
 days 365  years 5
years 5 r  weeks/yea22 day/week x 1 Factor  Exposure EffectsHealth Noncancer 
  
 
mg/kg/day 0.0001  
kg 45
kg/mg10  0.06 mg/day  200  mg/kg 403  Dose Exposure EffectsHealth Noncancer 
-6   
004.0
 days 365  years 70
years 5 r  weeks/yea22 day/week x 1 Factor  Exposure EffectsCancer 
  
mg/kg/day 0.000007  
kg 45
kg/mg10  0.004 mg/day  200  mg/kg 403  Dose Exposure EffectsCancer 
-6   
0.00001  2  0.000007 Risk Cancer   
NOTES: 
1.  The ATSDR Chronic MRL for Aroclor 1254 is 0.00002 mg/kg/day.     
2.  The EPA Oral Cancer Slope Factor for PCBs is 2.0 mg/kg/day-1. 
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3. Exposure Dose and Cancer Risk Calculations for Ingestion of On-Site Surface Soil Containing the 
Average Concentration of PCBs in the Area North of the On-Site Building by an Older Child 
After Remediation: 
 
06.0
 days 365  years 5
years 5 r  weeks/yea22 day/week x 1 Factor  Exposure EffectsHealth Noncancer 
  
 
mg/kg/day 0.0001  
kg 45
kg/mg10  0.06 mg/day  200  mg/kg 440  Dose Exposure EffectsHealth Noncancer 
-6   
004.0
 days 365  years 70
years 5 r  weeks/yea22 day/week x 1 Factor  Exposure EffectsCancer 
  
mg/kg/day 0.000008  
kg 45
kg/mg10  0.004 mg/day  200  mg/kg 440  Dose Exposure EffectsCancer 
-6   
0.00002  2  0.000008 Risk Cancer   
4. Exposure Dose and Cancer Risk Calculations for Ingestion of On-Site Surface Soil Containing the 
Average Concentration of PCBs in the Area South of the On-Site Building by an Older Child 
After Remediation: 
 
06.0
 days 365  years 5
years 5 r  weeks/yea22 day/week x 1 Factor  Exposure EffectsHealth Noncancer 
  
 
mg/kg/day 0.00001  
kg 45
kg/mg10  0.06 mg/day  200  mg/kg 50  Dose Exposure EffectsHealth Noncancer 
-6   
004.0
 days 365  years 70
years 5 r  weeks/yea22 day/week x 1 Factor  Exposure EffectsCancer 
  
mg/kg/day 0.0000009  
kg 45
kg/mg10  0.004 mg/day  200  mg/kg 50  Dose Exposure EffectsCancer 
-6   
0.000002  2  0.0000009 Risk Cancer   
NOTES: 
1.  The ATSDR Chronic MRL for Aroclor 1254 is 0.00002 mg/kg/day.     
2.  The EPA Oral Cancer Slope Factor for PCBs is 2.0 mg/kg/day-1. 
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Exposure Dose and Cancer Risk Calculation Formulas: 
 
Noncancer Health Effects Exposure Factor: 
 days 365  ED
ED  F  NC_EF 
  
Noncancer Health Effects Exposure Dose: 
BW
NC_EF CF  AFSA   SAF  [C]
  NC_D soil
  
Cancer Effects Exposure Factor: 
 days 365  years 70
ED  F  C_EF 
  
Cancer Effects Exposure Dose (Dermal Contact): 
BW
C_EF CF  AF SA   SAF  [C]
  C_D soil
  
Cancer Risk: 
CSF  C_D  CR   
Where: 
   NC_EF  = Noncancer Exposure Factor (unitless) 
   F  = Frequency of Exposure (days/year) 
   ED  = Years of Exposure (years) 
   NC_D   = Noncancer Exposure Dose (mg/kg/day) 
   [C]soil   = Analyte Concentration in Surface Soil (mg/kg) 
   SAF  = Soil Adherence Factor (mg/cm2) 
   SA  = Exposed Body Surface Area (cm2) 
AF  = Absorption Factor (Dermal) (unitless) 
   CF  = Conversion Factor (kg/mg) 
   BW  = Body Weight (kg) 
   C_EF  = Cancer Exposure Factor (unitless) 
   C_D   = Cancer Exposure Dose (mg/kg/day) 
   CR   = Cancer Risk (unitless) 
   CSF   = Cancer Slope Factor (mg/kg/day –1) 
 Assumptions: 
1. The receptor evaluated was an older child who trespasses on the site. 
2. The soil concentration was assumed as the average concentration of PCBs detected in the 
contaminated section of the site to reflect the range of contaminant concentrations that would likely 
have been contacted over time.  
3. The exposure factor was determined assuming the older child receptor was exposed to site soil 1 day 
per week, for 22 weeks per year (May through September) over a 5 year period.   
4. The average body weight of the older child receptor was assumed to be 45 kilograms. 
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1. Exposure Dose and Cancer Risk Calculations for Dermal Contact with On-Site Surface Soil 
Containing the Average Concentration of PCBs by an Older Child Prior to Remediation: 
 
06.0
 days 365  years 5
years 5r x  weaks/yea22 day/week  1  Factor Exposure EffectsHealth Noncancer 
  
 
mg/kg/day 0.00006  
kg 45
06.0kg/mg10 0.14  4100cm mg/cm 0.2  mg/kg 403  Dose Exposure EffectsHealth Noncancer 
-622 
 
004.0
 days 365  years 70
years 5 r  weeks/yea22 day/week  1 Factor  Exposure EffectsCancer 
  
 
mg/kg/day 0.000004  
kg 45
004.0kg/mg10 0.14 cm 4100  mg/cm 0.2  mg/kg 403  Dose Exposure EffectsHealth Cancer 
-622 
 
0.000008  2  0.000004 Risk Cancer   
 
 
 
2. Exposure Dose and Cancer Risk Calculations for Dermal Contact with On-Site Surface Soil 
Containing the Average Concentration of PCBs in the Area North of the On-Site Building by an 
Older Child After Remediation: 
 
06.0
 days 365  years 5
years 5r x  weaks/yea22 day/week  1  Factor Exposure EffectsHealth Noncancer 
  
 
mg/kg/day 0.00007  
kg 45
06.0kg/mg10 0.14  4100cm mg/cm 0.2  mg/kg 440  Dose Exposure EffectsHealth Noncancer 
-622 
 
004.0
 days 365  years 70
years 5 r  weeks/yea22 day/week  1 Factor  Exposure EffectsCancer 
  
 
mg/kg/day 0.000005  
kg 45
004.0kg/mg10 0.14 cm 4100  mg/cm 0.2  mg/kg 440  Dose Exposure EffectsHealth Cancer 
-622 
 
0.00001  2  0.000005 Risk Cancer   
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3. Exposure Dose and Cancer Risk Calculations for Dermal Contact with On-Site Surface Soil 
Containing the Average Concentration of PCBs in the Area South of the On-Site Building by an 
Older Child After Remediation: 
 
06.0
 days 365  years 5
years 5r x  weaks/yea22 day/week  1  Factor Exposure EffectsHealth Noncancer 
  
 
mg/kg/day 0.000008  
kg 45
06.0kg/mg10 0.14  4100cm mg/cm 0.2  mg/kg 50  Dose Exposure EffectsHealth Noncancer 
-622 
 
004.0
 days 365  years 70
years 5 r  weeks/yea22 day/week  1 Factor  Exposure EffectsCancer 
  
 
mg/kg/day 0.0000005  
kg 45
004.0kg/mg10 0.14 cm 4100  mg/cm 0.2  mg/kg 50  Dose Exposure EffectsHealth Cancer 
-622 
 
0.000001  2  0.0000005 Risk Cancer   
 
NOTES: 
1. The ATSDR Chronic MRL for Aroclor 1254 is 0.00002 mg/kg/day.     
2.  The EPA Oral Cancer Slope Factor for PCBs is 2.0 mg/kg/day-1. 
 86 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX C:  EXPOSURE DOSE AND CANCER RISK CALCULATIONS FOR 
EXPOSURE VIA INGESTION OF ON-SITE SURFACE SOIL AT THE FORMER 
TALLYRAND SITE 
 
 
APPENDIX C 
 
Exposure Dose and Cancer Risk Calculations for Exposure via Ingestion of On-Site Surface Soil 
Former Tallyrand Site, New Bedford, Massachusetts 
 
87 
Exposure Dose and Cancer Risk Calculation Formulas: 
 
Noncancer Health Effects Exposure Factor: 
 days 365  ED
ED  F  NC_EF 
  
Noncancer Health Effects Exposure Dose (Ingestion): 
BW
CF  NC_EF  IR  [C]
  NC_D soil
  
Cancer Effects Exposure Factor: 
 days 365  years 70
ED  F  C_EF 
  
Cancer Effects Exposure Dose (Ingestion): 
BW
CF  C_EF  IR  [C]
  C_D soil
  
Cancer Risk: 
CSF  C_D  CR   
Where: 
   NC_EF  = Noncancer Exposure Factor (unitless) 
   F  = Frequency of Exposure (days/year) 
   ED  = Years of Exposure (years) 
   NC_D   = Noncancer Exposure Dose (mg/kg/day) 
   [C]soil   = Analyte Concentration in Surface Soil (mg/kg) 
   IR   = Soil Ingestion Rate (mg/day) 
   CF   = Conversion Factor (kg/mg) 
   BW  = Body Weight (kg) 
   C_EF   = Cancer Exposure Factor (unitless) 
   C_D   = Cancer Exposure Dose (mg/kg/day) 
   CR   = Cancer Risk (unitless) 
   CSF   = Cancer Slope Factor (mg/kg/day –1) 
 Assumptions: 
1) The receptor evaluated was an older child who trespasses on the site. 
2) The soil concentration was assumed as the average concentration of PCBs detected in surface soil in 
the contaminated section of the site. 
3) The amount of soil ingested was assumed to be 200 milligrams per day for the older child. 
4) The exposure factor was determined assuming the older child receptor was exposed to on-site soil 1 
day per month, for 5 months per year (May through September) over a 5 year period.   
5) The average body weight of the older child receptor was assumed to be 45 kilograms. 
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1. Exposure Dose and Cancer Risk Calculations for Ingestion of On-Site Surface Soil Containing the 
Average Concentration of PCBs by an Older Child Prior to Remediation: 
 
014.0
 days 365  years 5
years 5 r months/yea 5x day/month  1 Factor  Exposure EffectsHealth Noncancer 
  
 
mg/kg/day 0.00005  
kg 45
kg/mg10  0.014 mg/day  200  mg/kg 887  Dose Exposure EffectsHealth Noncancer 
-6   
001.0
 days 365  years 70
years 5 r months/yea 5x day/month  1 Factor  Exposure EffectsCancer 
  
mg/kg/day 0.000004  
kg 45
kg/mg10  0.001 mg/day  200  mg/kg 887  Dose Exposure EffectsCancer 
-6   
0.000008  2  0.000004 Risk Cancer   
 
2. Exposure Dose and Cancer Risk Calculations for Ingestion of On-Site Surface Soil Containing the 
Maximum Concentration of PCBs by an Older Child After Remediation: 
 
014.0
 days 365  years 5
years 5 r months/yea 5x day/month  1 Factor  Exposure EffectsHealth Noncancer 
  
 
mg/kg/day 0.0000006  
kg 45
kg/mg10  0.014 mg/day  200  mg/kg 10  Dose Exposure EffectsHealth Noncancer 
-6   
001.0
 days 365  years 70
years 5 r months/yea 5x day/month  1 Factor  Exposure EffectsCancer 
  
mg/kg/day 0.00000004  
kg 45
kg/mg10  0.001 mg/day  200  mg/kg 10  Dose Exposure EffectsCancer 
-6   
0.00000008  2  0.00000004 Risk Cancer   
 
NOTES: 
1.  The ATSDR Chronic MRL for Aroclor 1254 is 0.00002 mg/kg/day.     
2.  The EPA Oral Cancer Slope Factor for PCBs is 2.0 mg/kg/day-1. 
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Exposure Dose and Cancer Risk Calculation Formulas: 
 
Noncancer Health Effects Exposure Factor: 
 days 365  ED
ED  F  NC_EF 
  
Noncancer Health Effects Exposure Dose: 
BW
NC_EF CF  AFSA   SAF  [C]
  NC_D soil
  
Cancer Effects Exposure Factor: 
 days 365  years 70
ED  F  C_EF 
  
Cancer Effects Exposure Dose (Dermal Contact): 
BW
C_EF CF  AF SA   SAF  [C]
  C_D soil
  
Cancer Risk: 
CSF  C_D  CR   
Where: 
   NC_EF  = Noncancer Exposure Factor (unitless) 
   F  = Frequency of Exposure (days/year) 
   ED  = Years of Exposure (years) 
   NC_D   = Noncancer Exposure Dose (mg/kg/day) 
   [C]soil   = Analyte Concentration in Surface Soil (mg/kg) 
   SAF  = Soil Adherence Factor (mg/cm2) 
   SA  = Exposed Body Surface Area (cm2) 
AF  = Absorption Factor (Dermal) (unitless) 
   CF  = Conversion Factor (kg/mg) 
   BW  = Body Weight (kg) 
   C_EF  = Cancer Exposure Factor (unitless) 
   C_D   = Cancer Exposure Dose (mg/kg/day) 
   CR   = Cancer Risk (unitless) 
   CSF   = Cancer Slope Factor (mg/kg/day –1) 
 Assumptions: 
1. The receptor evaluated was an older child who trespasses on the site. 
2. The soil concentration was assumed as the average concentration of PCBs detected in surface soil in 
the contaminated section of the site. 
3. The exposure factor was determined assuming the older child receptor was exposed to on-site soil 1 
day per month, for 22 months per year (May through September) over a 5 year period.   
4. The average body weight of the older child receptor was assumed to be 45 kilograms. 
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1. Exposure Dose and Cancer Risk Calculations for Dermal Contact with On-Site Surface Soil 
Containing the Average Concentration of PCBs by an Older Child Prior to Remediation: 
 
014.0
 days 365  years 5
years 5r x months/yea 5 day/month  1  Factor Exposure EffectsHealth Noncancer 
  
 
mg/kg/day 0.00003  
kg 45
014.0kg/mg10 0.14  4100cm mg/cm 0.2  mg/kg 887  Dose Exposure EffectsHealth Noncancer 
-622 
 
001.0
 days 365  years 70
years 5 r months/yea 5 day/month  1 Factor  Exposure EffectsCancer 
  
 
mg/kg/day 0.000002  
kg 45
001.0kg/mg10 0.14 cm 4100  mg/cm 0.2  mg/kg 887  Dose Exposure EffectsHealth Cancer 
-622 
 
0.000004  2  0.000002 Risk Cancer   
 
 
2. Exposure Dose and Cancer Risk Calculations for Dermal Contact with On-Site Surface Soil 
Containing the Average Concentration of PCBs by an Older Child After Remediation: 
 
014.0
 days 365  years 5
years 5r x months/yea 5 day/month  1  Factor Exposure EffectsHealth Noncancer 
  
 
mg/kg/day 0.0000004  
kg 45
014.0kg/mg10 0.14  4100cm mg/cm 0.2  mg/kg 10  Dose Exposure EffectsHealth Noncancer 
-622 
 
001.0
 days 365  years 70
years 5 r months/yea 5 day/month  1 Factor  Exposure EffectsCancer 
  
 
mg/kg/day 0.00000003  
kg 45
001.0kg/mg10 0.14 cm 4100  mg/cm 0.2  mg/kg 10  Dose Exposure EffectsHealth Cancer 
-622 
 
0.00000006  2  0.00000003 Risk Cancer   
 
 
NOTES: 
1. The ATSDR Chronic MRL for Aroclor 1254 is 0.00002 mg/kg/day.     
2.  The EPA Oral Cancer Slope Factor for PCBs is 2.0 mg/kg/day-1. 
 
 
 
